<SEC-DOCUMENT>0001437749-22-027745.txt : 20221118
<SEC-HEADER>0001437749-22-027745.hdr.sgml : 20221118
<ACCEPTANCE-DATETIME>20221118162202
ACCESSION NUMBER:		0001437749-22-027745
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20221118
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221118
DATE AS OF CHANGE:		20221118

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Genprex, Inc.
		CENTRAL INDEX KEY:			0001595248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				900772347
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38244
		FILM NUMBER:		221402215

	BUSINESS ADDRESS:	
		STREET 1:		1601 TRINITY STREET, BLDG. B
		STREET 2:		SUITE 3.322
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78712
		BUSINESS PHONE:		512-537-7997

	MAIL ADDRESS:	
		STREET 1:		1601 TRINITY STREET, BLDG. B
		STREET 2:		SUITE 3.322
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78712
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gnpx20221118_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:gnpx="http://www.gnpx.com/20221118"><head>
	<title>gnpx20221118_8k.htm</title>
	<!-- Created by RDG Portal -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-right: 10px; margin-left: 10px; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20228K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20228K" name="dei:EntityCentralIndexKey">0001595248</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="gnpx-20221118.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20228K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001595248</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-11-18</xbrli:startDate>
<xbrli:endDate>2022-11-18</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt 7.2pt;text-align:center;"><b>UNITED STATES</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt 7.2pt;text-align:center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><b>Washington, D.C. 20549</b>&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">&#xa0; &#xa0;</div>

<div style="background-color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;line-height:.15;margin:0pt 7.2pt;text-align:center;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt 7.2pt;text-align:center;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt 7.2pt;text-align:center;"><b>FORM <ix:nonNumeric contextRef="d20228K" name="dei:DocumentType"><b><b>8-K</b></b></ix:nonNumeric></b>&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">&#xa0; &#xa0;&#xa0;</div>

<div style="background-color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;line-height:.15;margin:0pt 7.2pt;text-align:center;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><b>CURRENT REPORT</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><b>PURSUANT TO SECTION 13 OR 15(d)</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><b>OF THE SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><span style="text-decoration: underline;"><b>November&#xa0;18, 2022</b></span></ix:nonNumeric></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">Date of report (Date of earliest event reported)</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:18pt;margin:0pt 7.2pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityRegistrantName"><span style="text-decoration: underline;"><b>GENPREX, INC.</b></span></ix:nonNumeric></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><b>(Exact name of registrant as specified in its charter)</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><b>&#xa0;</b></div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><span style="text-decoration: underline;"><b>Delaware</b></span></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:29.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityFileNumber"><span style="text-decoration: underline;"><b>001-38244</b></span></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityTaxIdentificationNumber"><span style="text-decoration: underline;"><b>90-0772347</b></span></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(State or other jurisdiction of</div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">incorporation or organization)</div>
			</td>
			<td style="vertical-align:top;width:29.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Commission File Number)</div>
			</td>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(I.R.S. Employer</div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Identification Number)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:35%;">&#xa0;</td>
			<td style="vertical-align:top;width:29.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:35%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><span style="text-decoration: underline;"><b><ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressAddressLine1"><span style="text-decoration: underline;"><b>3300 Bee Cave Road, #650-227</b></span></ix:nonNumeric>, <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressCityOrTown"><span style="text-decoration: underline;"><b>Austin</b></span></ix:nonNumeric>, <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressStateOrProvince"><span style="text-decoration: underline;"><b><span style="text-decoration: underline;"><b>TX</b></span></b></span></ix:nonNumeric></b></span></div>
			</td>
			<td style="vertical-align:top;width:29.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressPostalZipCode"><span style="text-decoration: underline;"><b>78746</b></span></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Address of principal executive offices)</div>
			</td>
			<td style="vertical-align:top;width:29.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Zip Code)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">Registrant&#8217;s telephone number, including area code: <span style="text-decoration: underline;"><b>(<ix:nonNumeric contextRef="d20228K" name="dei:CityAreaCode"><span style="text-decoration: underline;"><b>512</b></span></ix:nonNumeric>) <ix:nonNumeric contextRef="d20228K" name="dei:LocalPhoneNumber"><span style="text-decoration: underline;"><b>537-7997</b></span></ix:nonNumeric></b></span></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:5.7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:94.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:5.7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:94.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:5.7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:94.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:5.7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:94.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">Securities registered pursuant to Section&#xa0;12(b) of the Act:</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:37.8%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Title of each class</b></div>
			</td>
			<td style="vertical-align:bottom;border-bottom: 1px #000000;;width:1.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:15%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Trading</b></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Symbol(s)</b></div>
			</td>
			<td style="vertical-align:bottom;border-bottom: 1px #000000;;width:1.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:44.7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Name of each exchange on which registered</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;border-bottom:solid 1px #000000;;width:37.8%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric>, par value $0.001 per share</div>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:1.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:15%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" name="dei:TradingSymbol">GNPX</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:1.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:44.7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">The <ix:nonNumeric contextRef="d20228K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> Capital Market</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b&#8211;2 of the Securities Exchange Act of 1934 (&#167; 240.12b&#8211;2 of this chapter).</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">Emerging growth company&#xa0;<ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#xa0;<ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod">&#9746;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>Item 1.01 Entry into a Material Definitive Agreement.</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 7.2pt; text-align: left;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;">On November 18, 2022, Genprex, Inc. (the &#8220;Company&#8221;) entered into an Equity Distribution Agreement (the &#8220;Agreement&#8221;) with JMP Securities LLC, serving as agent (the &#8220;Agent&#8221;) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), having an aggregate offering price of up to $50.0 million (the &#8220;Shares&#8221;) through the Placement Agent (the &#8220;Offering&#8221;). Any Shares offered and sold in the Offering will be issued pursuant to the Company&#8217;s Registration Statement on Form S-3 filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on June 12, 2020, as amended on July 1, 2020, which was declared effective on July 17, 2020, the prospectus supplement relating to the Offering filed with the SEC on November 18, 2022 and any applicable additional prospectus supplements related to the Offering that form a part of the Registration Statement. A copy of the opinion of Lowenstein Sandler LLP relating to the legality of the issuance and sale of the Shares is attached as Exhibit 5.1&#xa0;hereto.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;">The Agent may sell the Shares by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415 of the Securities Act of 1933, as amended, including, without limitation, sales made through The Nasdaq Capital Market (&#8220;Nasdaq&#8221;) or on any other existing trading market for the Common Stock. The Agent will use commercially reasonable efforts to sell the Shares from time to time consistent with its normal sales practices and applicable federal rules, regulations and Nasdaq rules, based upon instructions from the Company (including any price, time or size limits or other customary parameters or conditions the Company may impose). The Company will pay the Agent a commission equal to three percent (3%) of the gross sales proceeds of any Shares sold through the Agent under the Agreement, and also has provided the Agent with customary indemnification and contribution rights.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;">The Agent is not required to sell any specific number or dollar amount of securities, but will use commercially reasonable efforts to sell, on behalf of the Company, all of the shares of common stock requested to be sold by the Company, consistent with its normal trading and sales practices, on mutually agreed terms between the Agent and the Company. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;">The foregoing description of the Agreement is not complete and is qualified in its entirety by reference to the full text of the Agreement, a copy of which is filed herewith as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference. A copy of the opinion of Lowenstein Sandler LLP relating to the legality of the issuance and sale of the shares in the Offering is attached as Exhibit 5.1 hereto.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;">This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.</div>

<div style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; margin: 0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;"><b>Item 9.01: Financial Statements and Exhibits.</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">(d) Exhibits.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:8.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Exhibit</b></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Number</b></div>
			</td>
			<td style="vertical-align:bottom;width:4.8%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&#xa0;</b></div>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:86.2%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&#xa0;Description</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:8.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:4.8%;">&#xa0;</td>
			<td style="vertical-align:middle;width:86.2%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; text-align: center;">1.1</td>
			<td style="vertical-align:middle;width:4.8%;">&#xa0;</td>
			<td style="vertical-align:middle;width:86.2%;"><a href="ex_449033.htm" style="-sec-extract:exhibit;">Equity Distribution Agreement, dated November 18, 2022 by and among Genprex, Inc. and JMP Securities LLC.</a></td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; text-align: center;">&#xa0;</td>
			<td style="vertical-align:middle;width:4.8%;">&#xa0;</td>
			<td style="vertical-align:middle;width:86.2%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; text-align: center;">5.1</td>
			<td style="vertical-align:middle;width:4.8%;">&#xa0;</td>
			<td style="vertical-align:middle;width:86.2%;"><a href="ex_449034.htm" style="-sec-extract:exhibit;">Opinion of Lowenstein Sandler LLP.</a></td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; text-align: center;">&#xa0;</td>
			<td style="vertical-align:middle;width:4.8%;">&#xa0;</td>
			<td style="vertical-align:middle;width:86.2%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; text-align: center;">23.1</td>
			<td style="vertical-align:middle;width:4.8%;">&#xa0;</td>
			<td style="vertical-align:middle;width:86.2%;"><a href="ex_449034.htm" style="-sec-extract:exhibit;">Consent of Lowenstein Sandler LLP (contained in Exhibit 5.1).</a></td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:8.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:4.8%;">&#xa0;</td>
			<td style="vertical-align:middle;width:86.2%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; text-align: center;">104</td>
			<td style="vertical-align:middle;width:4.8%;">&#xa0;</td>
			<td style="vertical-align:middle;width:86.2%;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.3pt;text-align:left;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.3pt; text-align: center;"><b>SIGNATURES</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:55.1%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;border-bottom: 1px #000000;;width:33.1%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>GENPREX, INC.</b></div>
			</td>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:11.8%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:55.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:3.5%;">&#xa0;</td>
			<td style="vertical-align:top;width:29.6%;">&#xa0;</td>
			<td style="vertical-align:top;width:11.8%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:55.1%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Date: November 18, 2022</div>
			</td>
			<td style="vertical-align:top;width:3.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">By:</div>
			</td>
			<td style="vertical-align:top;border-bottom:solid 1px #000000;;width:29.6%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i>/s/ Ryan Confer</i></div>
			</td>
			<td style="vertical-align:top;width:11.8%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:55.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:3.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:29.6%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Ryan Confer</div>
			</td>
			<td style="vertical-align:top;width:11.8%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 55.1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 3.5%;">&#xa0;</td>
			<td style="vertical-align: top; width: 29.6%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Chief Financial Officer</div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(Principal Financial Officer)</div>
			</td>
			<td style="vertical-align: top; width: 11.8%;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex_449033.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<html><head>
	<title>HTML Editor</title>
	<meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">EXHIBIT 1.1</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="border-bottom:double 3px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Genprex, Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Common Stock</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>EQUITY DISTRIBUTION AGREEMENT</u></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Dated: November 18, 2022</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">TABLE OF CONTENTS</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 1.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Description of Securities.</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 2.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Placements.</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 3.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sale of Placement Securities by the Placement Agent&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 4.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Suspension of Sales</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 5.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Representations and Warranties.</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 6.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sale and Delivery to the Placement Agent; Settlement.</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 7.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Covenants of the Company</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 8.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Payment of Expenses.</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 9.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conditions of the Placement Agent&#8217;s Obligations</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 10.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indemnity and Contribution by the Company and the Placement Agent</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 11.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Representations, Warranties and Agreements to Survive Delivery</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 12.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Termination of Agreement.</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 13.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Notices</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 14.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parties</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 15.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Adjustments for Stock Splits</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 16.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Governing Law and Time</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 17.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Consent to Jurisdiction</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 18.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Effect of Headings</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 19.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Permitted Free Writing Prospectuses</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 20.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Absence of Fiduciary Relationship</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 21.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Counterparts</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECTION 22.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Entire Agreement; Amendments; Severability; Waiver</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.6%;">&nbsp;</td>
			<td style="vertical-align:top;width:16.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>EXHIBITS</u></p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">Exhibit A &#8211; Form of Placement Notice</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:-36pt;">Exhibit B &#8211; Authorized Individuals for Placement Notices and Acceptances</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:-36pt;">Exhibit C &#8211; Compensation</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:-36pt;">Exhibit D &#8211; Officer Certificate</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:-36pt;">[Exhibit E &#8211; Issuer Free Writing Prospectuses]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:-36pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>GENPREX INC.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">Common Stock</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><u>EQUITY DISTRIBUTION AGREEMENT</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">November 18, 2022</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">JMP Securities LLC</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">600 Montgomery Street, 11<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup> Floor</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">San Francisco, California 94111</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Ladies and Gentlemen:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">Genprex Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), confirms its agreement (this &#8220;<u>Agreement</u>&#8221;) with JMP Securities LLC (the &#8220;<u>Placement Agent</u>&#8221;), as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 1. <u>Description of Securities</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">The Company agrees that, from time to time during the term of this Agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through the Placement Agent, acting as agent, shares of common stock of the Company (the &#8220;<u>Securities</u>&#8221;), par value $0.001 per share (the &#8220;<u>Common Stock</u>&#8221;) provided, however, that in no event shall the Company issue or sell through the Placement Agent (including issue Placement Notices (as defined below) for) such number or dollar amount of the Securities that would (a) exceed the number or dollar amount of shares of Common Stock registered on the effective Registration Statement (defined below) pursuant to which the offering is being made, (b) exceed the number of authorized but unissued shares of Common Stock less any shares of Common Stock issuable upon the exercise, conversion or exchange of any outstanding equity securities of the Company or otherwise reserved from the Company&#8217;s authorized capital stock, (c) exceed the number or dollar amount of shares of Common Stock permitted to be sold under Form S-3 (including General Instruction I.B.6 thereof, if applicable), or (d) exceed the number or dollar amount of shares of Common Stock for which the Company has filed a Prospectus (as defined below) (the lesser of (a), (b), (c) and (d), the &#8220;<u>Maximum Amount</u>&#8221;). Notwithstanding anything to the contrary contained herein, except as set forth in a Placement Notice (as defined below) the parties hereto agree that compliance with the limitations set forth in this Section 1 on the number of the Securities issued and sold under this Agreement shall be the sole responsibility of the Company, and the Placement Agent shall have no obligation in connection with such compliance. The issuance and sale of the Securities through the Placement Agent will be effected pursuant to the Registration Statement (as defined below) filed by the Company and declared effective by the Securities and Exchange Commission (the &#8220;<u>Commission</u>&#8221;), although nothing in this Agreement shall be construed as requiring the Company to use the Registration Statement to offer, sell or issue the Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">The Company has filed in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the &#8220;<u>Securities Act</u>&#8221;), with the Commission a registration statement on Form S-3 (File No. 333-239134), including a base prospectus, relating to certain securities, including the Securities to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the &#8220;<u>Exchange Act</u>&#8221;). The Company has prepared a prospectus or a prospectus supplement to the base prospectus included as part of such registration statement specifically relating to the Securities (the &#8220;<u>Prospectus Supplement</u>&#8221;). The Company will furnish to the Placement Agent, for use by the Placement Agent, copies of the prospectus included as part of such registration statement, as supplemented by the Prospectus Supplement, relating to the Securities. The Company may file one or more additional registration statements from time to time that will contain a base prospectus and related prospectus or prospectus supplement (which shall be a Prospectus Supplement) with respect to the Placement Securities (as defined below). Except where the context otherwise requires, such registration statement, as amended when it became effective, including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act or deemed to be a part of such registration statement pursuant to Rule 430B or 462(b) of the Securities Act, or any subsequent registration statement on Form S-3 filed pursuant to Rule 415(a)(6) under the Securities Act by the Company to cover any securities registered pursuant to the Registration Statement, including any Securities, as a result of the end of the three year period described in Rule 415(a)(5) of the Securities Act, is herein called the &#8220;<u>Registration Statement</u>.&#8221; The base prospectus, including all documents incorporated or deemed incorporated therein by reference, included in the Registration Statement, as it may be supplemented by the Prospectus Supplement, in the form in which such prospectus and/or Prospectus Supplement have most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act is herein called the &#8220;<u>Prospectus</u>.&#8221; Any reference herein to the Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to refer to and include the documents incorporated by reference therein, and any reference herein to the terms &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document with the Commission deemed to be incorporated by reference therein. Any reference herein to financial statements and schedules and other information that is &#8220;contained,&#8221; &#8220;included&#8221; or &#8220;stated&#8221; in the Registration Statement or the Prospectus or to any amendment or supplement thereto (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference in the Registration Statement or the Prospectus, as the case may be. Any reference herein to the Registration Statement, any Rule 462(b) Registration Statement (as defined below), the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to the Commission&#8217;s Electronic Data Gathering, Analysis and Retrieval system (&#8220;<u>EDGAR</u>&#8221;); all references in this Agreement to any Issuer Free Writing Prospectus (other than any Issuer Free Writing Prospectuses (as defined below) that, pursuant to Rule 433 under the Securities Act, are not required to be filed with the Commission) shall be deemed to include the copy thereof filed with the Commission pursuant to EDGAR.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 2. <u>Placements</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">Each time that the Company wishes to issue and sell the Securities hereunder (each, a &#8220;<u>Placement</u>&#8221;), it will notify the Placement Agent by email notice (or other method mutually agreed to in writing by the parties) of the parameters in accordance with which it desires the Securities to be sold, which shall at a minimum include the number or dollar amount of Securities to be issued (the &#8220;<u>Placement Securities</u>&#8221;), the time period during which sales are requested to be made, any limitation on the number of Securities that may be sold in any one day and any minimum price below which sales may not be made (a &#8220;<u>Placement Notice</u>&#8221;), a form of which containing such minimum sales parameters necessary is attached hereto as <u>Exhibit A</u>. The Placement Notice shall originate from any of the individuals from the Company set forth on <u>Exhibit B</u> (with a copy to each of the other individuals from the Company listed on such exhibit), and shall be addressed to each of the individuals from the Placement Agent set forth on <u>Exhibit B</u>, as such <u>Exhibit B</u> may be amended from time to time.&nbsp; Provided that the Company is otherwise in compliance with the terms of this Agreement, the Placement Notice shall be effective immediately unless and until (i) the Placement Agent declines to accept the terms contained therein for any reason, in its sole discretion, (ii) the entire amount of the Placement Securities thereunder have been sold, (iii) the Company suspends or terminates the Placement Notice, (iv) this Agreement has been terminated under the provisions of Section 9 or Section 12 or (v) either party shall have suspended the sale of the Placement Securities in accordance with Section 4 below. The amount of any discount, commission or other compensation to be paid by the Company to the Placement Agent in connection with the sale of the Placement Securities shall be calculated in accordance with the terms set forth in <u>Exhibit C</u>. It is expressly acknowledged and agreed that neither the Company nor the Placement Agent will have any obligation whatsoever with respect to a Placement or any Placement Securities unless and until the Company delivers a Placement Notice to the Placement Agent and either (i) the Placement Agent accepts the terms of such Placement Notice or (ii) where the terms of such Placement Notice are amended, the Company accepts such amended terms by means of an Acceptance pursuant to the terms set forth above, and then only upon the terms specified in the Placement Notice (as amended by the corresponding Acceptance, if applicable) and herein. In the event of a conflict between the terms of this Agreement and the terms of a Placement Notice (as amended by the corresponding Acceptance, if applicable), the terms of the Placement Notice (as amended by the corresponding Acceptance, if applicable) will control. The term &#8220;Business Day&#8221; means each Monday, Tuesday, Wednesday, Thursday or Friday that is not a day on which banking institutions in New York are generally authorized or obligated by law or executive order to close.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 3. <u>Sale of Placement Securities by the Placement Agent.</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">Subject to the provisions of Section 6(a), the Placement Agent, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices to sell the Placement Securities up to the amount specified in, and otherwise in accordance with the terms of such Placement Notice (as amended by the corresponding Acceptance, if applicable). The Placement Agent will provide written confirmation to the Company no later than the opening of the Trading Day (as defined below) immediately following the Trading Day on which it has made sales of Placement Securities hereunder setting forth the number of Placement Securities sold on such day, the compensation payable by the Company to the Placement Agent pursuant to Section 2 with respect to such sales, and the Net Proceeds (as defined below) payable to the Company, with an itemization of the deductions made by the Placement Agent (as set forth in Section 6(b)) from the gross proceeds that it receives from such sales. Subject to the terms of the Placement Notice (as amended by the corresponding Acceptance, if applicable), the Placement Agent may sell Placement Securities by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415(a)(4) of the Securities Act, including without limitation sales made directly on the Nasdaq Capital Market (the &#8220;<u>Nasdaq</u>&#8221;) or on any other existing trading market for the Common Stock. If specified in a Placement Notice (as amended by the corresponding Acceptance, if applicable), the Placement Agent may also sell Placement Securities by any other method permitted by law, including but not limited to in privately negotiated transactions. For the purposes hereof, &#8220;<u>Trading Day</u>&#8221; means any day on which shares of Common Stock are purchased and sold on the principal market on which the Common Stock is listed or quoted and during which there has been no market disruption of, unscheduled closing of or suspension of trading on such principal market.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 4. <u>Suspension of Sales</u>. The Company or the Placement Agent may, upon notice to the other party in writing (including by email correspondence to each of the individuals of the other party set forth on <u>Exhibit B</u>, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by email correspondence to each of the individuals of the other party set forth on <u>Exhibit B</u>), suspend any sale of Placement Securities (a &#8220;<u>Suspension</u>&#8221;); provided, however, that such suspension shall not affect or impair either party&#8217;s obligations with respect to any Placement Securities sold hereunder prior to the receipt of such notice. Each of the parties agrees that no such notice under this Section 4 shall be effective against the other unless it is made to one of the individuals named on <u>Exhibit B</u> hereto, as such Exhibit may be amended from time to time. While a Suspension is in effect any obligations under Sections 7(o), 7(p) and 7(q) with respect to delivery of certificates, opinions, or comfort letters to the Placement Agent, shall be waived.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 5. <u>Representations and Warranties</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(a) <i>Representations and Warranties by the Company</i>. The Company represents and warrants to the Placement Agent as of the date hereof and as of each Representation Date (as defined herein) on which a certificate is required to be delivered pursuant to Section 7(o) of this Agreement and as of the time of each sale of any Securities pursuant to this Agreement (the &#8220;<u>Applicable Time</u>&#8221;), and agrees with the Placement Agent, as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(1) <u>Compliance with Registration Requirements</u>. The Securities have been duly registered under the Securities Act pursuant to the Registration Statement. The Registration Statement has become effective under the Securities Act, or, with respect to any registration statement to be filed to register the offer and sale of the Securities pursuant to Rule 462(b) under the Securities Act, including the documents incorporated by reference therein and the Rule 430A Information, (a &#8220;<u>Rule 462(b) Registration Statement</u>&#8221;), will be filed with the Commission and become effective under the Securities Act no later than 10:00 P.M., Eastern Time, on the date of determination of the public offering price for the Securities, and no stop order preventing or suspending the use of any base prospectus, the Prospectus Supplement, the Prospectus or any Permitted Free Writing Prospectus (as defined below), or the effectiveness of the Registration Statement or any Rule 462(b) Registration Statement and no proceedings for such purpose have been instituted or are pending or, to the knowledge of the Company, are contemplated by the Commission, and any request on the part of the Commission for additional information has been complied with.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:36pt;">At the respective times each of the Registration Statement, any Rule 462(b) Registration Statement and any post-effective amendments thereto became or becomes effective and as of the date hereof, the Registration Statement, any Rule 462(b) Registration Statement and any amendments and supplements thereto complied and will comply in all material respects with the requirements of the Securities Act. The&nbsp;&nbsp; Company meets the requirements for use of Form S-3, as set forth in the General Instructions thereto. The Registration Statement, as of the date hereof and each effective date with respect thereto, did not and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. Neither the Prospectus nor any amendments or supplements thereto, as of their respective dates, and at each Applicable Time and Settlement Date (as defined below), as the case may be, included or will include an untrue statement of a material fact or omitted or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:36pt;">The representations and warranties set forth in the immediately preceding paragraph shall not apply to statements in or omissions from the Registration Statement or the Prospectus, as amended or supplemented, made in reliance upon and in conformity with information furnished to the Company in writing by the Placement Agent expressly for use therein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:36pt;">The copies of the Registration Statement and any Rule 462(b) Registration Statement and any amendments thereto, any other preliminary prospectus, each Issuer Free Writing Prospectus (as defined below) that is required to be filed with the Commission pursuant to Rule 433 under the Securities Act and the Prospectus and any amendments or supplements thereto delivered and to be delivered to the Placement Agent (electronically or otherwise) in connection with the offering of the Securities were and will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T. &#8220;<u>Issuer Free Writing Prospectus</u>&#8221; means any &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433 under the Securities Act, relating to the Securities that (i) is required to be filed with the Commission by the Company, (ii) is a &#8220;road show&#8221; that is a &#8220;written communication&#8221; within the meaning of Rule 433(d)(8)(i) under the Securities Act whether or not required to be filed with the Commission, or (iii) is exempt from filing pursuant to Rule 433(d)(5)(i) under the Securities Act because it contains a description of the Securities or of the offering that does not reflect the final terms, and all free writing prospectuses that are listed in <u>Exhibit E</u> hereto, in each case in the form furnished (electronically or otherwise) to the Placement Agent for use in connection with the offering of the Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:36pt;">Each Issuer Free Writing Prospectus relating to the Securities, as of its issue date and as of each Applicable Time and Settlement Date (as defined below), did not, does not and will not include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement or the Prospectus, including any incorporated document deemed to be a part thereof that has not been superseded or modified; each Issuer Free Writing Prospectus, as supplemented by and taken together with the Prospectus, as of the Applicable Time and Settlement Date (as defined below), will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances, prevailing at that time, not misleading. The foregoing sentence does not apply to statements in or omissions from any issuer free writing prospectus based upon and in conformity with written information furnished to the Company by the Placement Agent specifically for use therein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:36pt;">Each document incorporated by reference in the Registration Statement or the Prospectus heretofore filed, when it was filed (or, if any amendment with respect to any such document was filed, when such amendment was filed), conformed in all material respects with the requirements of the Exchange Act, and any further documents so filed and incorporated after the date of this Agreement will, when they are filed, conform in all material respects with the requirements of the Exchange Act; no such document when it was filed (or, if an amendment with respect to any such document was filed, when such amendment was filed), contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading; and no such document, when it is filed, will contain an untrue statement of a material fact or will omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(2) <u>Company Capitalization</u>. The Company has an authorized capitalization as set forth in the Prospectus; the outstanding shares of capital stock of the Company have been duly and validly authorized and issued and are fully paid and nonassessable and are free of any preemptive or similar rights.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(3) <u>Disclosure Regarding Outstanding Securities</u>. Except as disclosed in the Prospectus, there are no outstanding (A) securities or obligations of the Company or the subsidiaries of the Company required to be set forth in Exhibit 21.1 to the Company&#8217;s most recent Form 10-K (each a &#8220;<u>Subsidiary</u>,&#8221; and together, the &#8220;<u>Subsidiaries</u>&#8221;, if the Company has no Subsidiaries, all other references to the Subsidiary or Subsidiaries shall be disregarded) convertible into or exchangeable for any capital stock of or partnership interests, membership interests or other equity interests, as the case may be, in the Company or any such Subsidiary, (B) warrants, rights or options to subscribe for or purchase from the Company or any Subsidiary any such capital stock or any such convertible or exchangeable securities or obligations, or (C) obligations of the Company or any Subsidiary to issue, sell, transfer or acquire any securities or obligations, any such convertible or exchangeable securities or obligations, or any such warrants, rights or options the existence of which, in each case (A), (B) and (C), is required to be disclosed in the Registration Statement and the Prospectus and are not so disclosed.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(4) <u>Good Standing</u>. Each of the Company and its Subsidiaries is duly organized and validly existing as a corporation, limited liability company or other organization in good standing under the laws of the jurisdiction of its incorporation or organization with full corporate or organizational power and authority to own, lease and operate its properties and to conduct its business as presently conducted and as described in the Registration Statement and the Prospectus (and any amendment or supplement thereto) and is duly registered and qualified to conduct its business and is in good standing in each jurisdiction or place where the nature of its properties or the conduct of its business requires such registration or qualification, except where the failure to so register or qualify has not had or will not have a material adverse effect on the condition (financial or other), business, properties, net worth or results of operations or prospects of the Company and its Subsidiaries (a &#8220;<u>Material Adverse Effect</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(5) <u>No Prohibition on Dividends Payable by the Subsidiaries</u>. Except as disclosed in the Prospectus, (i) neither the Company nor any of its Subsidiaries has paid or declared any dividends or other distributions with respect to its capital stock and the Company is not in default under the terms of any class of capital stock of the Company or any outstanding debt obligations and (ii) no Subsidiary is contractually prohibited or restricted, directly or indirectly, from paying dividends or from making any other distribution with respect to the outstanding membership interests of such Subsidiary or from repaying to the Company or another subsidiary of the Company any amounts which may from time to time become due under any loans or advances to such Subsidiary from the Company or another subsidiary of the Company, or from transferring such Subsidiary&#8217;s property or assets to the Company or another subsidiary of the Company except for any such prohibitions and restrictions that would not individually or in the aggregate reasonably be expected to have a Material Adverse Effect or to the extent that any such restriction would currently materially limit the Company&#8217;s ability to pay dividends or that would be reasonably likely to materially limit the future payment of dividends on Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(6) <u>Absence of Defaults</u>. Except as disclosed in the Prospectus, neither the Company nor any Subsidiary is in breach of or in default under (nor has any event occurred which with notice, lapse of time, or both would constitute a breach of, or default under), its respective organizational documents, or in the performance or observance of any obligation, agreement, covenant or condition contained in any license, indenture, mortgage, deed of trust, loan or credit agreement or other agreement or instrument to which the Company or any Subsidiary is a party or by which any of them or their respective properties or assets is bound, except for such breaches or defaults which would not reasonably be expected to have a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(7) <u>Absence of Conflicts</u>. The execution, delivery and performance of this Agreement and consummation of the transactions contemplated herein will not (A) conflict with, or result in any breach of, or constitute a default under (nor constitute any event which with notice, lapse of time, or both would constitute a breach of, or default under): (1) any provision of the organizational documents of the Company or any Subsidiary, or (2) any provision of any license, indenture, mortgage, deed of trust, loan or credit agreement or other agreement or instrument to which the Company or any Subsidiary is a party or by which any of them or their respective assets or properties may be bound or affected, or under any federal, state, local or foreign law, regulation or rule or any decree, judgment or order applicable to the Company or any Subsidiary, except in the case of clause (2) for such breaches or defaults which would not reasonably be expected to have a Material Adverse Effect; or (B) result in the creation or imposition of any lien, charge, claim or encumbrance upon any property or asset of the Company or any Subsidiary, except for such liens, charges, claims or encumbrances which would not reasonably be expected to have a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(8) <u>Authorization of Agreement</u>. This Agreement has been duly authorized, executed and delivered by the Company and is a legal, valid and binding agreement of the Company enforceable against the Company in accordance with its terms, except as may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217; rights generally, and by general equitable principles, and except to the extent that the indemnification and contribution provisions of Section 10 hereof may be limited by federal or state securities laws and public policy considerations in respect thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(9) <u>Absence of Further Requirements</u>. No approval, authorization, consent or order of or registration or filing with any court, federal, state, local or foreign governmental or regulatory commission, board, body, authority, official or agency is required in connection with the Company&#8217;s execution, delivery and performance of this Agreement, the consummation of the transactions contemplated herein by the Company, including the Company&#8217;s issuance, sale and delivery of the Securities, other than (A) such as have been obtained, or will have been obtained at the Settlement Date (as defined below), as the case may be, under the Securities Act and the Exchange Act, (B) any necessary qualification under the securities or &#8220;blue sky&#8221; laws of the various jurisdictions in which the Securities are being offered by the Placement Agent, (C) any required filings or approvals under FINRA (as defined below) and the Nasdaq, or (D) any such approvals, authorizations, consents, orders, or filings that if not obtained or made, would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect or which would not reasonably be expected to have a material adverse effect on the Company&#8217;s ability to perform their agreed upon obligations under this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(10) <u>Possession of Licenses and Permits</u>. Each of the Company and the Subsidiaries has all necessary licenses, authorizations, consents and approvals and has made all necessary filings required under any federal, state, local or foreign law, regulation or rule, and has obtained all necessary authorizations, consents and approvals from other persons, required in order to conduct their respective businesses as described in the Prospectus, except to the extent that any failure to have any such licenses, authorizations, consents or approvals, to make any such filings or to obtain any such authorizations, consents or approvals would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; neither the Company nor any of the Subsidiaries is in violation of, in default under, or has received any notice regarding a possible violation, default or revocation of any such license, authorization, consent or approval or any federal, state, local or foreign law, regulation or rule or any decree, order or judgment applicable to the Company or any of the Subsidiaries the effect of which would reasonably be expected to result in a Material Adverse Change.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(11) <u>Permitted Free Writing Prospectuses</u>. Except for the Issuer Free Writing Prospectuses identified in <u>Exhibit E</u> hereto, the Company has not prepared, used or referred to, and will not, without the prior consent of the Placement Agent, prepare, use or refer to, any Free Writing Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(12) <u>Company Not an Ineligible Issuer</u>. (i) At the earliest time after the filing of the Registration Statement that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) of the Securities Act) of the Securities and (ii) as of the date hereof, the Company was not and is not an Ineligible Issuer (as defined in Rule 405 of the Securities Act Regulations), without taking account of any determination by the Commission pursuant to Rule 405 of the Securities Act that it is not necessary that the Company be considered an Ineligible Issuer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(13) <u>Filing of Registration Statement</u>. The Company filed the Registration Statement with the Commission before using any Issuer Free Writing Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(14) <u>Absence of Proceedings</u>. Except as disclosed in the Prospectus, there are no actions, suits, proceedings, inquiries or investigations pending or, to the knowledge of the Company, threatened against the Company or any Subsidiary or, to the extent that such proceeding affects the properties or assets of the Company or any Subsidiary, any of their respective officers and directors or to which the properties, assets or rights of any such entity are subject, at law or in equity, before or by any federal, state, local or foreign governmental or regulatory commission, board, body, authority, arbitral panel or agency which could result in a judgment, decree, award or order that would reasonably be expected to have a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(15) <u>No Labor Disputes</u>. No labor problem or dispute with the employees of the Company or any of its Subsidiaries exists, or, to the Company&#8217;s knowledge, is threatened or imminent, which would reasonably be expected to result in a Material Adverse Effect. The Company is not aware that any key employee or significant group of employees of the Company or any of its Subsidiaries plans to terminate employment with the Company or any of its Subsidiaries. Neither the Company nor any of its Subsidiaries has engaged in any unfair labor practice, and except for matters which would not, individually or in the aggregate, result in a Material Adverse Effect, (i) there is (A) no unfair labor practice complaint pending or, to the Company&#8217;s knowledge, threatened against the Company or any of its Subsidiaries before the National Labor Relations Board, and no grievance or arbitration proceeding arising out of or under collective bargaining agreements is pending or to the Company&#8217;s knowledge, threatened, (B) no strike, labor dispute, slowdown or stoppage pending or, to the Company&#8217;s knowledge, threatened against the Company or any of its Subsidiaries and (C) no union representation dispute currently existing concerning the employees of the Company or any of its Subsidiaries and (ii) to the Company&#8217;s knowledge, (A) no union organizing activities are currently taking place concerning the employees of the Company or any of its Subsidiaries and (B) there has been no violation of any federal, state, local or foreign law relating to discrimination in the hiring, promotion or pay of employees, any applicable wage or hour laws or any provision of the Employee Retirement Income Security Act of 1974, as amended, including the regulations and published interpretations thereunder (&#8220;<u>ERISA</u>&#8221;) concerning the employees of the Company or any of its Subsidiaries.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(16) <u>Financial Statements</u>. The consolidated financial statements of the Company and its Subsidiaries present fairly the consolidated financial position of the Company and its Subsidiaries, as of the dates indicated and consolidated results of operations and changes in financial position and cash flows for the periods specified; such financial statements have been prepared in conformity with generally accepted accounting principles as applied in the United States and on a consistent basis during the periods involved and in accordance with Regulation S-X promulgated by the Commission; the financial statement schedules included or incorporated by reference in the Prospectus have been compiled on a basis consistent with the financial statements; no pro forma financial information, financial statements or supporting schedules other than the historical financial statements are required to be included in the Registration Statement or the Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(17) <u>Independent Accountants</u>. Daszkal Bolton LLP, whose reports on the consolidated financial statements of the Company and its Subsidiaries constitute part of the Prospectus, is, and was during the periods covered by its reports, independent as required by the Securities Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(18) <u>No Material Adverse Effect</u>. Subsequent to the respective dates of the most recent financial statements in the Prospectus, and except as may be otherwise disclosed in the Prospectus, there has not been (A) any Material Adverse Effect or any development or transaction that would reasonably be expected to result in a Material Adverse Effect, whether or not arising in the ordinary course of business, (B) any transaction that is material to the Company and the Subsidiaries taken as a whole, contemplated or entered into by the Company or any of the Subsidiaries, (C) any obligation, contingent or otherwise, directly or indirectly incurred by the Company or any Subsidiary that is material to the Company and the Subsidiaries taken as a whole or (D) any dividend or distribution of any kind declared, paid or made by the Company on any class of its capital stock or any Subsidiary on any of its equity interests.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(19) <u>Description of Securities</u>. The Common Stock conforms in all material respects to the descriptions thereof contained in the Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(20) <u>Absence of Registration Rights</u>. Except as disclosed in the Registration Statement and Prospectus, there are no persons with registration or other similar rights to have any equity or debt securities of the Company or the Subsidiaries, including securities which are convertible into or exchangeable or redeemable for equity securities of the Company or the Subsidiaries, registered pursuant to the Registration Statement or otherwise registered by the Company under the Securities Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(21) <u>Authorization of Securities</u>. The Securities have been duly authorized and, when issued and duly delivered against payment therefor as contemplated by this Agreement, will be validly issued, fully paid and non-assessable, free and clear of any pledge, lien, encumbrance, security interest or other claim, and the issuance and sale of the Securities by the Company is not subject to preemptive or other similar rights arising by operation of law, under the organizational documents of the Company or any Subsidiary or under any agreement to which the Company or any Subsidiary is a party or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(22) <u>Nasdaq</u>. The Common Stock has been registered under Section 12(b) of the Exchange Act.&nbsp;&nbsp; The Placement Securities shall either have been approved for listing on the Exchange, subject only to notice of issuance, or the Company shall have filed an application for listing of the Placement Securities on the Exchange at, or prior to, the issuance of any Placement Notice.&nbsp; The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from Nasdaq, nor has the Company received any notification that the Commission or the Nasdaq is contemplating terminating such registration or listing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(23) <u>Absence of Stabilization and Manipulation</u>. The Company has not taken, directly or indirectly, any action which is designed to or which has constituted or which might reasonably be expected to cause or result in stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(24) <u>Absence of Registration Requirements</u>. Neither the Company nor any of its affiliates (A) is required to register as a &#8220;broker&#8221; or &#8220;dealer&#8221; in accordance with the provisions of the Exchange Act, or (B) directly, or indirectly through one or more intermediaries, controls or has any other association with (within the meaning of Article I of the By-laws of the Financial Industry Regulatory Authority, Inc. (&#8220;<u>FINRA</u>&#8221;)) any member firm of FINRA.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(25) <u>Form of Certificates</u>. The form of certificate used to evidence the Common Stock complies in all material respects with all applicable statutory requirements, with any applicable requirements of the organizational documents of the Company and the requirements of the Nasdaq.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(26) <u>Title to Property</u>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property, if any, and good title to all personal property, if any, owned by them, in each case free and clear of all liens, security interests, pledges, charges, encumbrances, claims, restrictions, mortgages and defects in such title (collectively, the &#8220;<u>Encumbrances</u>&#8221;), except such Encumbrances that are disclosed in the Prospectus or would not reasonably be expected to have a Material Adverse Effect; any real or personal property leased by the Company or any Subsidiary is held under a lease which is a valid and binding agreement, enforceable against the Company or such Subsidiary (to the extent a party thereto) and, to the Company&#8217;s knowledge, the other parties thereto, except (A) as may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217; rights generally, and by general principles of equity, and except to the extent that the indemnification and contribution provisions of Section 10 hereof may be limited by federal or state securities laws and public policy considerations in respect thereof, (B) as otherwise disclosed in the Prospectus or (C) for such exceptions that would not reasonably be expected to have a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(27) <u>Description of Legal Proceedings</u>. The descriptions of legal or governmental proceedings, contracts, leases and other legal documents in the Prospectus constitute fair and accurate summaries of such proceedings or documents, and there are no legal or governmental proceedings, contracts, leases or other documents that are known to the Company of a character required to be described in the Prospectus or filed as exhibits to the Registration Statement which are not so described or filed; all agreements between the Company or any of the Subsidiaries and third parties expressly referenced in the Prospectus are legal, valid and binding obligations of the Company or the Subsidiaries, to the extent a party thereto, and, to the knowledge of the Company, of the other parties thereto, enforceable against the Company or Subsidiaries in accordance with their respective terms, except to the extent enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217; rights generally and by general equitable principles and neither the Company nor any Subsidiary is in breach or default under any such agreements, except to the extent that the indemnification and contribution may be limited by federal or state securities laws and public policy considerations in respect thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(28) <u>Consents and Permits.</u> Except as disclosed in the Registration Statement and the Prospectus, the Company and its Subsidiaries have made all filings, applications and submissions required by, possesses and is operating in material compliance with, all approvals, licenses, certificates, certifications, clearances, consents, grants, exemptions, marks, notifications, orders, permits and other authorizations issued by, the appropriate federal, state or foreign Governmental Authority (including, without limitation, the United States Food and Drug Administration (the &#8220;<u>FDA</u>&#8221;), the United States Drug Enforcement Administration or any other foreign, federal, state, provincial, court or local government or regulatory authorities including self-regulatory organizations engaged in the regulation of clinical trials, pharmaceuticals, biologics or biohazardous substances or materials) necessary for the ownership or lease of their respective properties or to conduct its businesses as described in the Registration Statement and the Prospectus (collectively, &#8220;<u>Permits</u>&#8221;), except for such Permits the failure of which to possess, obtain or make the same would not have a Material Adverse Effect; the Company and its Subsidiaries are in compliance with the terms and conditions of all such Permits, except where the failure to be in compliance would not have a Material Adverse Effect; all of the Permits are valid and in full force and effect, except where any invalidity, individually or in the aggregate, would not be reasonably expected to have a Material Adverse Effect; and neither the Company nor any of its Subsidiaries has received any written notice relating to the limitation, revocation, cancellation, suspension, modification or non-renewal of any such Permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a Material Adverse Effect, or has any reason to believe that any such license, certificate, permit or authorization will not be renewed in the ordinary course. To the extent required by applicable laws and regulations of the FDA, the Company or the applicable Subsidiary has submitted to the FDA an Investigational New Drug Application or amendment or supplement thereto for each clinical trial it has conducted or sponsored or is conducting or sponsoring; all such submissions were in material compliance with applicable laws and rules and regulations when submitted and no material deficiencies have been asserted by the FDA with respect to any such submissions. &#8220;<u>Governmental Authority</u>&#8221; shall mean (i) any federal, provincial, state, local, municipal, national or international government or governmental authority, regulatory or administrative agency, governmental commission, department, board, bureau, agency or instrumentality, court, tribunal, arbitrator or arbitral body (public or private); (ii) any self-regulatory organization; or (iii) any political subdivision of any of the foregoing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(29) <u>Regulatory Filings</u>. Except as disclosed in the Registration Statement and the Prospectus, neither the Company nor any of its Subsidiaries has failed to file with the applicable Governmental Authorities (including, without limitation, the FDA, or any foreign, federal, state, provincial or local Governmental Authority performing functions similar to those performed by the FDA) any required filing, declaration, listing, registration, report or submission, except for such failures that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect; except as disclosed in the Registration Statement and the Prospectus, all such filings, declarations, listings, registrations, reports or submissions were in compliance with applicable laws when filed and no deficiencies have been asserted by any applicable regulatory authority with respect to any such filings, declarations, listings, registrations, reports or submissions, except for any deficiencies that, individually or in the aggregate, would not have a Material Adverse Effect. The Company has operated and currently is, in all material respects, in compliance with the United States Federal Food, Drug, and Cosmetic Act, all applicable rules and regulations of the FDA and other federal, state, local and foreign Governmental Authority exercising comparable authority. The Company has no knowledge of any studies, tests or trials not described in the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(30) <u>Intellectual Property</u>. Except as disclosed in the Registration Statement and the Prospectus, to the Company&#8217;s knowledge, the Company and its Subsidiaries own, possess, license or have other rights to use all foreign and domestic patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology, Internet domain names, know-how and other intellectual property (collectively, the &#8220;<u>Intellectual Property</u>&#8221;), necessary for the conduct of their respective businesses as now conducted except to the extent that the failure to own, possess, license or otherwise hold adequate rights to use such Intellectual Property would not, individually or in the aggregate, have a Material Adverse Effect. Except as disclosed in the Registration Statement and the Prospectus (i) there are no rights of third parties to any such Intellectual Property owned by the Company and its Subsidiaries; (ii) to the Company&#8217;s knowledge, there is no infringement by third parties of any such Intellectual Property; (iii) there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others challenging the Company&#8217;s and its Subsidiaries&#8217; rights in or to any such Intellectual Property, and the Company is unaware of any facts which could form a reasonable basis for any such action, suit, proceeding or claim; (iv) there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property; (v) there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others that the Company and its Subsidiaries infringe or otherwise violate any patent, trademark, copyright, trade secret or other proprietary rights of others; (vi) to the Company&#8217;s knowledge, there is no third-party U.S. patent or published U.S. patent application which contains claims for which an Interference Proceeding (as defined in 35 U.S.C. &#167; 135) has been commenced against any patent or patent application described in the Prospectus as being owned by or licensed to the Company; and (vii) the Company and its Subsidiaries have complied with the terms of each agreement pursuant to which Intellectual Property has been licensed to the Company or such Subsidiary, and all such agreements are in full force and effect, except, in the case of any of clauses (i)-(vii) above, for any such infringement by third parties or any such pending or threatened suit, action, proceeding or claim as would not, individually or in the aggregate, result in a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(31) <u>Clinical Studies</u>. To the Company&#8217;s knowledge, the preclinical studies and tests and clinical trials described in the Prospectus were, and, if still pending, are being conducted in all material respects in accordance with experimental protocols, procedures and controls compliant with, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company; the descriptions of such studies, tests and trials, and the results thereof, contained in the Prospectus are, to the knowledge of the Company, accurate and complete in all material respects; the Company is not aware of any tests, studies or trials not described in the Prospectus, the results of which reasonably call into question the results of the tests, studies and trials described in the Prospectus; and the Company has not received any written notice or correspondence from the FDA or any foreign, state or local Governmental Authority exercising comparable authority or any institutional review board or comparable authority requiring the termination, suspension, clinical hold or material modification of any tests, studies or trials.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(32) <u>Compliance with Laws</u>. Each of the Company and its Subsidiaries: (A) is and at all times has been in compliance with all statutes, rules, or regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product manufactured or distributed by the Company or its Subsidiaries (&#8220;<u>Applicable Laws</u>&#8221;), except as could not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect; (B) has not received any FDA Form 483, notice of adverse finding, warning letter, untitled letter or other correspondence or notice from the FDA or any other Governmental Authority alleging or asserting noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws (&#8220;<u>Authorizations</u>&#8221;), except for such noncompliance as would not individually or in the aggregate, have a Material Adverse Effect; (C) possesses all material Authorizations and such Authorizations are valid and in full force and effect and are not in material violation of any term of any such Authorizations, except as would not individually or in the aggregate, have a Material Adverse Effect; (D) has not received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Governmental Authority or third party alleging that any product operation or activity is in violation of any Applicable Laws or Authorizations and has no knowledge that any such Governmental Authority or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding, except as would not individually or in the aggregate, have a Material Adverse Effect; (E) has not received notice that any Governmental Authority has taken, is taking or intends to take action to materially limit, suspend, materially modify or revoke any Authorizations and has no knowledge that any such Governmental Authority is considering such action; (F) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and correct on the date filed (or were corrected or supplemented by a subsequent submission), except as would not individually or in the aggregate, have a Material Adverse Effect; and (G) has not, either voluntarily or involuntarily, initiated, conducted, or issued or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert, post sale warning, &#8220;dear healthcare provider&#8221; letter, or other notice or action relating to the alleged lack of safety or efficacy of any product or any alleged product defect or violation and, to the Company&#8217;s knowledge, no third party has initiated, conducted or intends to initiate any such notice or action.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(33) <u>Market Capitalization</u>. At the time the Registration Statement was declared effective, and at the time the Company&#8217;s most recent Annual Report on Form 10-K was filed with the Commission, the Company met or will meet the then applicable requirements for the use of Form S-3 under the Securities Act, including, but not limited to, General Instruction I.B.1 of Form S-3. The Company is not a shell company (as defined in Rule 405 under the Securities Act) and has not been a shell company for at least 12 calendar months previously and if it has been a shell company at any time previously, has filed current Form 10 information (as defined in General Instruction I.B.6 of Form S-3) with the Commission at least 12 calendar months previously reflecting its status as an entity that is not a shell company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(34) <u>Accounting Controls</u>. Except as set forth in the Prospectus, the Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that, with respect to the consolidated Company, (A) transactions are executed in accordance with management&#8217;s general or specific authorizations; (B) transactions are recorded as necessary to permit preparation of the consolidated financial statements of the Company in conformity with generally accepted accounting principles as applied in the United States and to maintain asset accountability; (C) access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and (D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(35) <u>Disclosure Controls</u>. Except as set forth in the Prospectus, (A) the Company has established and maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Exchange Act), which (1) are designed to ensure that material information relating to the Company, including its consolidated Subsidiaries, is made known to the Company&#8217;s principal executive officer and its principal financial officer by others within those entities, particularly during the periods in which the periodic reports required under the Exchange Act are being prepared, (2) have been evaluated for effectiveness as of the end of the Company&#8217;s last fiscal year, and (3) are effective in all material respects to perform the functions for which they were established, and (B) based on the evaluation of the Company&#8217;s disclosure controls and procedures described above, the Company is not aware of (1) any material weakness in the design or operation of internal control over financial reporting which is reasonably likely to adversely affect the Company&#8217;s ability to record, process, summarize and report financial information, or (2) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal control over financial reporting. Since the most recent evaluation of the Company&#8217;s disclosure controls and procedures described above, there have been no significant changes in internal control over financial reporting or in other factors that could significantly affect internal control over financial reporting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(36) <u>ERISA</u>. The Company and the Subsidiaries are in compliance in all material respects with all presently applicable provisions of ERISA; no &#8220;reportable event&#8221; (as defined in ERISA) has occurred with respect to any &#8220;pension plan&#8221; (as defined in ERISA) for which the Company or any of the Subsidiaries would have any material liability; neither the Company nor any of the Subsidiaries has incurred and none of them expect to incur any material liability under (A) Title IV of ERISA with respect to termination of, or withdrawal from, any &#8220;pension plan&#8221; or (B) Section 412 or 4971 of the Internal Revenue Code of 1986, as amended, including the regulations and published interpretations thereunder (&#8220;<u>Code</u>&#8221;); each &#8220;pension plan&#8221; for which the Company or any of the Subsidiaries would have any liability that is intended to be qualified under Section 401(a) of the Code is so qualified in all material respects and nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(37) <u>Tax Returns</u>. The Company and each of the Subsidiaries has filed on a timely basis all material federal, state, local and foreign tax returns required to be filed through the date hereof or have properly requested extensions thereof, and all such tax returns are true, correct and complete in all material respects, and have paid all material taxes required to be paid, including any tax assessment, fine or penalty levied against the Company or any of the Subsidiaries; and no material tax deficiency has been asserted against any such entity, nor does any such entity know of any tax deficiency which is likely to be asserted against any such entity which, individually or in the aggregate, if determined adversely to any such entity, would reasonably be expected to have a Material Adverse Effect; all material tax liabilities are adequately provided for on the respective books of such entities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(38) <u>Tax Advice</u>. The Company has not relied upon the Placement Agent or legal counsel for the Placement Agent for any legal, tax or accounting advice in connection with the offering and sale of the Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(39) <u>Insurance</u>. The Company maintains insurance (in each case, issued by insurers of recognized financial responsibility) of the types and in the amounts generally deemed adequate for the business of the Company and its Subsidiary, including, but not limited to, directors and officers liability insurance, insurance covering personal property owned or leased by the Company and the Subsidiaries against theft, damage, destruction, acts of vandalism, , all of which insurance is in full force and effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(40) <u>Environmental Laws</u>. The Company and the Subsidiaries have received all permits, licenses or other approvals required of them under applicable federal and state occupational safety and health and environmental laws, regulations and rules to conduct the business of the consolidated Company, and the Company and the Subsidiaries are in compliance with all terms and conditions of any such permits, licenses or approvals, except for any failure to have required permits, licenses or other approvals or to comply with the terms and conditions of such permits, licenses or approvals which would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(41) <u>Absence of Impermissible Transactions</u>. None of the Company, any of the Subsidiaries or, to the knowledge of the Company, any officer or director of the Company, or any of the Subsidiaries, while serving in these roles, has at any time (A) made any contributions to any candidate for political office, or failed to disclose fully any such contributions, in violation of law, (B) made any payment of funds or received or retained any funds in violation of any law, rule or regulation or of a character required to be disclosed in the Prospectus, or (C) engaged in any material transactions, maintained any bank account or used any material corporate funds except for transactions, bank accounts and funds which have been or are, as applicable, reflected in the books and records of the Company and the Subsidiaries.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(42) <u>Issued Securities</u>. All securities issued by the Company, any of the Subsidiaries or any trusts established by the Company or any of the Subsidiaries have been issued and sold in compliance with (A) all applicable federal and state securities laws and (B) the applicable corporate or partnership law of the jurisdiction of incorporation of the Company or Subsidiary, as applicable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(43) <u>Hazardous Materials</u>. To the Company&#8217;s knowledge neither the Company nor any of the Subsidiaries has any liability under any applicable environmental, health, safety or similar law or otherwise relating to any Hazardous Material (as hereinafter defined) and there are no notices of potential liability or claims pending or, to the knowledge of the Company, threatened against the Company or any of the Subsidiaries or concerning any of the Properties under any applicable environmental, health, safety or similar law or otherwise relating to any Hazardous Material, except for such liabilities or claims which would not reasonably be expected to have a Material Adverse Effect; neither the Company nor any of the Subsidiaries or, to the knowledge of the Company, any other person, has contaminated or caused conditions that threaten to contaminate any of the Properties with Hazardous Materials, except for such contamination or threats of contamination which would not reasonably be expected to have a Material Adverse Effect; neither the Properties nor any other land ever owned by the Company or any of the Subsidiaries is included on or, to the knowledge of the Company, is proposed for inclusion on the National Priorities List pursuant to the Comprehensive Environmental Response, Compensation, and Liability Act, 42 U.S.C. &#167; 9601 <u>et seq.</u>, or any similar list or inventory of contaminated properties. As used herein, &#8220;<u>Hazardous Material</u>&#8221; shall mean any hazardous material, hazardous waste, hazardous substance, hazardous constituent, toxic substance, pollutant, contaminant, asbestos, petroleum, petroleum waste, radioactive material, biohazardous material, explosive or any other material, the presence of which in the environment is prohibited, regulated, or serves as the basis of liability, as defined, listed, or regulated by any applicable federal, state, or local environmental law, ordinance, rule, or regulation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(44) <u>Compliance with Securities Laws</u>. In connection with the offer and sale of the Securities, the Company has not offered shares of its Common Stock or any other securities convertible into or exchangeable or exercisable or redeemable for Common Stock in a manner in violation of the Securities Act; and the Company has not distributed and will not distribute any offering material in connection with the offer and sale of the Securities except for the Prospectus Supplement, the Prospectus and any Issuer Free Writing Prospectus or the Registration Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(45) <u>Lending Relationship</u>. Except as disclosed in the Prospectus, neither the Company nor any of its Subsidiaries has any outstanding borrowings from, or is a party to any line of credit, credit agreement or other credit facility or otherwise has a borrowing relationship with, any bank or other lending institution affiliated with the Placement Agent, and the Company does not intend to use any of the proceeds from the sale of the Securities to repay any debt owed to the Placement Agent or any affiliate thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(46) <u>Absence of Finders</u><u>&#8217;</u><u> Fees</u>. The Company has not incurred any liability for any finder&#8217;s fees or similar payments in connection with the transactions herein contemplated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(47) <u>No Other Contracts</u>. Other than this Agreement, there are no contracts, agreements or understandings between the Company or any of its Subsidiaries and any person that would give rise to a valid claim against the Company or any of its Subsidiaries or the Placement Agent for a brokerage commission, finder&#8217;s fee or other like payment with respect to the consummation of the transactions contemplated by this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(48) <u>Proprietary Trading by the Placement Agent.</u> The Company acknowledges and agrees that the Placement Agent has informed the Company that the Placement Agent may, to the extent permitted under the Securities Act and the Exchange Act, purchase and sell shares of Common Stock for its own account while this Agreement is in effect, and shall be under no obligation to purchase Securities on a principal basis pursuant to this Agreement, except as otherwise agreed by the Placement Agent in the Placement Notice (as amended by the corresponding Acceptance, if applicable); <i>provided</i>, that no such purchase or sales shall take place while a Placement Notice is in effect (except (i) as agreed by the Placement Agent in the Placement Notice (as amended by the corresponding Acceptance, if applicable) or (ii) to the extent the Placement Agent may engage in sales of Placement Securities purchased or deemed purchased from the Company as a &#8220;riskless principal&#8221; or in a similar capacity).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(49) <u>FINRA Matters</u>. All of the information provided to the Placement Agent or to counsel for the Placement Agent by the Company in connection with letters, filings or other supplemental information provided to the FINRA pursuant to FINRA Conduct Rule 5110 or 5121, as applicable, is true, complete and correct.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(50) <u>Related Party Transactions</u>. Except as disclosed in the Prospectus, no relationship, direct or indirect, exists between or among the Company or any of the Subsidiaries on the one hand, and the directors, officers, stockholders, customers or suppliers of the Company or any of the Subsidiaries on the other hand, that is required by the Securities Act to be described in the Prospectus and which is not so described.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(51) <u>Compliance with Sarbanes-Oxley</u>. The Company and the Subsidiaries and to the knowledge of the Company the officers and directors of the Company and the Subsidiaries, in their capacities as such, are, and at the Settlement Date (as defined below) and any Applicable Time will be, in compliance in all material respects with the provisions of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated thereunder or implementing the provisions thereof (the &#8220;<u>Sarbanes-Oxley Act</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(52) <u>Investment Company Act</u>. The Company is not and, after giving effect to the offering and sale of the Securities, will not be an &#8220;investment company&#8221;, as such terms are defined in the Investment Company Act of 1940, as amended (the &#8220;<u>Investment Company Act</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(53) <u>Statistical and Market Data</u>. The statistical and market related data included in the Prospectus are based on or derived from sources that the Company reasonably believes to be reliable and accurate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(54) <u>FCPA</u>. Neither the Company nor any Subsidiary nor any director or officer of the Company or its Subsidiaries: (i) has used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) has made any direct or indirect unlawful contribution or payment to any official of, or candidate for, or any employee of, any U.S. federal, state, local or foreign office from corporate funds; (iii) has made any bribe, unlawful rebate, payoff, influence payment, kickback or other unlawful payment; or (iv) is aware of or has taken any action, directly or indirectly, that would result in a violation by such Persons of the OECD Convention on Bribery of Foreign Public Officials in International Business Transactions (&#8220;<u>OECD Convention</u>&#8221;), the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (collectively, the &#8220;<u>FCPA</u>&#8221;), including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &#8220;foreign official&#8221; (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA, or any similar law or regulation to which the Company, any director, officer, agent, employee, affiliate or other person associated with or acting on behalf of the Company is subject. The Company and its affiliates have each conducted their businesses in compliance with the FCPA and the OECD Convention and any applicable similar law or regulation and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith. The foregoing representation and warranty shall also be deemed given regarding laws of non-U.S. jurisdictions similar to the FCPA.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(55) <u>Sanctions</u>. Neither the Company nor any of its Subsidiaries nor, to the Company&#8217;s knowledge, or to the knowledge of the Company, any director or officer of the Company is currently subject to any sanctions (&#8220;Sanctions&#8221;) administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;<u>OFAC</u>&#8221;), the United Nations Security Council (&#8220;<u>UNSC</u>&#8221;), the European Union, Her Majesty&#8217;s Treasury and the Foreign and Commonwealth Office of the United Kingdom (&#8220;<u>HMT</u>&#8221;), or any similar sanctions imposed by any other body, governmental or other, to which the Company is subject (collectively, &#8220;<u>other economic sanctions</u>&#8221;); nor is the Company or any of its Subsidiaries located, organized or resident in a country or territory that is the subject or the target of Sanctions, including, without limitation, Crimea, Cuba, Iran, North Korea, and Syria; and the Company will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partner or other Person or entity, for the purpose of financing the activities of any Person currently subject to any Sanctions. For the past five years, the Company and its Subsidiaries have not knowingly engaged in and are not now knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any country subject to Sanctions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(56) <u>Money Laundering Laws</u>. The operations of the Company are and have been conducted at all times in material compliance with applicable financial record-keeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of jurisdictions where the Company conducts business, the applicable rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#8220;<u>Money Laundering Laws</u>&#8221;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company with respect to the Money Laundering Laws is pending or, to the Company&#8217;s knowledge, threatened.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:72pt;">(57) <u>Cybersecurity</u>. There has been no security breach or other compromise of or relating to any of the information technology and computer systems, networks, hardware, software, data (including the data of its customers, employees, suppliers, vendors and any third party data maintained by or on behalf of the Company or any of its Subsidiaries), equipment or technology owned, held or used by or for the Company or any of its Subsidiaries (collectively, the &#8220;<u>IT Systems and Data</u>&#8221;), except for those that have been remedied without material cost or liability or the duty to notify any other person, nor are there any incidents under internal review or investigations relating to the same and (i) the Company has not been notified of, and has no knowledge of any facts that would reasonably be expected to result in, any material security breach or other compromise to the IT Systems and Data; (ii) the Company and its Subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to (x) the collection, use, transfer, storage, protection, disposal and/or disclosure of personally identifiable information collected from or provided by third parties, (y) the privacy and security of the IT Systems and Data and (z) the protection of the IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, in the case of this clause (ii), individually or in the aggregate, have a Material Adverse Effect; and (iii) the Company and its Subsidiaries have taken commercially reasonable steps to protect the IT Systems and Data, including by implementing backup, security and disaster recovery plans, procedures and technology necessary to protect such IT Systems and Data.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(b) <i>Certificates</i>. Any certificate signed by any officer of the Company delivered to the Placement Agent or to counsel for the Placement Agent pursuant to the terms or provisions of this Agreement shall be deemed a representation and warranty by the Company to the Placement Agent as to the matters covered thereby.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 6. <u>Sale and Delivery to the Placement Agent; Settlement</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(a) <i>Sale of Placement Securities</i>. On the basis of the representations and warranties herein contained and subject to the terms and conditions herein set forth, upon the Placement Agent&#8217;s acceptance of the terms of a Placement Notice or upon receipt by the Placement Agent of an Acceptance, as the case may be, and unless the sale of the Placement Securities described therein has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement, the Placement Agent, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable laws and regulations to sell such Placement Securities up to the amount specified, and otherwise in accordance with the terms of such Placement Notice. The Company acknowledges and agrees that (i) there can be no assurance that the Placement Agent will be successful in selling Placement Securities, (ii) the Placement Agent will incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Securities for any reason other than a failure by the Placement Agent to use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable laws and regulations to sell such Placement Securities as required under this Section 6, and (iii) the Placement Agent shall be under no obligation to purchase Securities on a principal basis pursuant to this Agreement, except as otherwise agreed by the Placement Agent in the Placement Notice (as amended by the corresponding Acceptance, if applicable).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(b) <i>Settlement of Placement Securities</i>. Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement Securities will occur on the second (2nd) Trading Day (or such earlier day as is industry practice for regular-way trading) following the date on which such sales are made (each, a &#8220;<u>Settlement Date</u>&#8221;). The Placement Agent shall notify the Company in writing (including by email correspondence to each of the individuals set forth on Exhibit B) of each sale of Placement Securities no later than the opening of the Trading Day immediately following the Trading Day on which it has made sales of Placement Securities hereunder. The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement Securities sold (the &#8220;<u>Net Proceeds</u>&#8221;) will be equal to the aggregate sales price received by the Placement Agent at which such Placement Securities were sold, after deduction for (i) the Placement Agent&#8217;s commission, discount or other compensation for such sales payable by the Company pursuant to Section 2 hereof and (ii) any other amounts due and payable by the Company to the Placement Agent hereunder pursuant to Section 8 hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(c) <i>Delivery of Placement Securities</i>. On or before each Settlement Date, concurrently with the receipt by the Company of the Net Proceeds due to the Company in respect of such Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer book-entry interest in the Placement Securities being sold by crediting the Placement Agent&#8217;s or its designee&#8217;s account (provided the Placement Agent shall have given the Company written notice of such designee prior to the Settlement Date) at The Depository Trust Company through its Deposit and Withdrawal at Custodian System or by such other means of delivery through the facilities of the Depository Trust Company as may be mutually agreed upon by the parties hereto which in all cases shall be freely tradable, transferable, registered shares in good deliverable form. On each Settlement Date, the Placement Agent will deliver the related Net Proceeds in same day funds to an account designated by the Company on, or prior to, the Settlement Date. The Company agrees that if the Company, or its transfer agent (if applicable), defaults in its obligation to deliver Placement Securities on a Settlement Date (other than as a result of a failure by the Placement Agent to provide instructions for delivery), the Company agrees that, in addition to and in no way limiting the rights and obligations set forth in Section 10(a) hereto, it will (i) hold the Placement Agent harmless against any loss, claim, suit, liability, debt, cause of action, damage, or reasonable and documented expense (including reasonable legal fees and expenses), as incurred, arising out of or in connection with such default by the Company and (ii) pay to the Placement Agent (without duplication) any commission, discount, or other compensation to which it would otherwise have been entitled absent such default.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(d) <i>Denominations; Registration</i>. If requested by the Placement Agent at least two (2) Business Days prior to the Settlement Date, then in lieu of electronic transfer, certificates for the Securities shall be in such denominations and registered in such names as the Placement Agent shall have specified in such request. The certificates for the Securities will be made available for examination and packaging by the Placement Agent in The City of New York not later than noon (Eastern Time) on the Business Day prior to the Settlement Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 7. <u>Covenants of the Company</u>. The Company covenants with the Placement Agent as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(a) <i>Registration Statement Amendment</i>. After the date of this Agreement and during any period in which a Prospectus relating to any Placement Securities is required to be delivered by the Placement Agent under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act or similar rule), (i) the Company will notify the Placement Agent promptly of the time when any subsequent amendment to the Registration Statement, other than documents incorporated by reference, has been filed with the Commission and/or has become effective or any subsequent supplement to the Prospectus has been filed and of any comment letter from the Commission or any request by the Commission for any amendment or supplement to the Registration Statement or Prospectus or for additional information; (ii) the Company will prepare and file with the Commission, promptly upon the Placement Agent&#8217;s reasonable request, any amendments or supplements to the Registration Statement or Prospectus that, in the Placement Agent&#8217;s reasonable opinion, may be necessary or advisable in connection with the distribution of the Placement Securities by the Placement Agent (<i>provided, however</i>, that the failure of the Placement Agent to make such request shall not relieve the Company of any obligation or liability hereunder, or affect the Placement Agent&#8217;s right to rely on the representations and warranties made by the Company in this Agreement), and provided, further, that the only remedy that the Placement Agent shall have with respect to the failure to make such filing shall be to cease making any sales under this Agreement until such amendment or supplement is filed; (iii) the Company will not file any amendment or supplement to the Registration Statement or Prospectus, other than documents incorporated by reference, relating to the Placement Securities or a security convertible into the Placement Securities unless a copy thereof has been submitted to the Placement Agent within a reasonable period of time before the filing and the Placement Agent has not reasonably objected thereto (<i>provided, however</i>, that the failure of the Placement Agent to make such objection shall not relieve the Company of any obligation or liability hereunder, or affect the Placement Agent&#8217;s right to rely on the representations and warranties made by the Company in this Agreement) and the Company will furnish to the Placement Agent at the time of filing thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or Prospectus, except for those documents available via EDGAR; and (iv) the Company will cause each amendment or supplement to the Prospectus, other than documents incorporated by reference, to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act (without reliance on Rule 424(b)(8) of the Securities Act).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(b) <i>Notice of Commission Stop Orders</i>. The Company will advise the Placement Agent, promptly after it receives notice or obtains knowledge thereof, of the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or of any other order preventing or suspending the use of the Prospectus or any Issuer Free Writing Prospectus, or of the suspension of the qualification of the Placement Securities for offering or sale in any jurisdiction or of the loss or suspension of any exemption from any such qualification, or of the initiation or threatening of any proceedings for any of such purposes, or of any examination pursuant to Section 8(e) of the Securities Act concerning the Registration Statement or if the Company becomes the subject of a proceeding under Section 8A of the Securities Act in connection with the offering of the Securities. The Company will use commercially reasonable efforts to prevent the issuance of any stop order, the suspension of any qualification of the Securities for offering or sale and any loss or suspension of any exemption from any such qualification, and if any such stop order is issued or any such suspension or loss occurs, to obtain the lifting thereof at the earliest possible moment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(c) <i>Delivery of Registration Statement and Prospectus.</i> Except to the extent such documents have been publicly filed with the Commission pursuant to EDGAR, the Company will furnish to the Placement Agent and its counsel (at the expense of the Company) copies of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments and supplements to the Registration Statement or Prospectus, and any Issuer Free Writing Prospectuses, that are filed with the Commission during any period in which a Prospectus relating to the Placement Securities is required to be delivered under the Securities Act (including all documents filed with the Commission during such period that are deemed to be incorporated by reference therein), in each case as soon as reasonably practicable and in such quantities and at such locations as the Placement Agent may from time to time reasonably request.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(d) <i>Continued Compliance with Securities Laws. </i>If at any time when a Prospectus is required by the Securities Act or the Exchange Act to be delivered in connection with a pending sale of the Placement Securities (including, without limitation, pursuant to Rule 172 under the Securities Act or similar rule), any event shall occur or condition shall exist as a result of which it is necessary to amend the Registration Statement together with the Prospectus in order that the Prospectus will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein not misleading in the light of the circumstances existing at the time it is delivered to a purchaser, or if it shall be necessary at any such time to amend the Registration Statement together with the Prospectus in order to comply with the requirements of the Securities Act, the Company will promptly notify the Placement Agent to suspend the offering of Placement Securities during such period and the Company will promptly prepare and file with the Commission such amendment or supplement as may be necessary to correct such statement or omission or to make the Registration Statement and the Prospectus comply with such requirements, provided, however, that the Company may delay any such amendment or supplement if, in the reasonable judgment of the Company, it is in the best interest of the Company to do so, provided no Placement Notice is in effect during such time, and the Company will furnish to the Placement Agent such number of copies of such amendment or supplement as the Placement Agent may reasonably request. If at any time following the issuance of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted, conflicts or would conflict with the information contained in the Registration Statement or the Prospectus or included, includes or would include an untrue statement of a material fact or together with the Prospectus omitted, omits or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances, prevailing at that subsequent time, not misleading, the Company will promptly notify the Placement Agent to suspend the offering of Placement Securities during such period and the Company will, subject to Section 7(a) hereof, promptly amend or supplement such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission provided, however, that the Company may delay any such amendment or supplement if, in the reasonable judgment of the Company, it is in the best interest of the Company to do so, provided that no Placement Notice is in effect during such time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(e) <i>Blue Sky and Other Qualifications</i>. The Company will use its commercially reasonable efforts, in cooperation with the Placement Agent, to qualify the Placement Securities for offering and sale, or to obtain an exemption for the Securities to be offered and sold, under the applicable securities laws of such states and other jurisdictions (domestic or foreign) as the Placement Agent may designate and to maintain such qualifications and exemptions in effect for so long as required for the distribution of the Securities (but in no event for less than one year from the date of this Agreement); <i>provided</i>, <i>however</i>, that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject. In each jurisdiction in which the Placement Securities have been so qualified or exempt, the Company will file such statements and reports as may be required by the laws of such jurisdiction to continue such qualification or exemption, as the case may be, in effect for so long as required for the distribution of the Placement Securities (but in no event for less than one year from the date of this Agreement).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(f) <i>Rule 158</i>. The Company will timely file such reports pursuant to the Exchange Act as are necessary in order to make generally available to its securityholders as soon as practicable an earnings statement for the purposes of, and to provide to the Placement Agent the benefits contemplated by, the last paragraph of Section 11(a) of the Securities Act.&nbsp; For the avoidance of doubt, the Company&#8217;s compliance with the reporting requirements of the Exchange Act shall be deemed to satisfy this Section 7(f).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(g) <i>Use of Proceeds</i>. The Company will use the net proceeds received by it from the sale of the Securities in the manner specified in the Prospectus under &#8220;Use of Proceeds.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(h) <i>Listing</i>. During any period in which the Prospectus relating to the Placement Securities is required to be delivered by the Placement Agent under the Securities Act with respect to a pending sale of the Placement Securities (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act or similar rule), the Company will use its commercially reasonable efforts to cause the Placement Securities to be listed on the Nasdaq.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(i) <i>Filings with the Nasdaq</i>. The Company will timely seek to file with the Nasdaq all material documents and notices required by the Nasdaq of companies that have securities traded on the Nasdaq.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(j) <i>Reporting Requirements</i>. The Company, during any period when the Prospectus is required to be delivered under the Securities Act and the Exchange Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act or similar rule), will file all documents required to be filed with the Commission pursuant to the Exchange Act within the time periods required by the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(k) <i>Notice of Other Sales</i>. During the period beginning on the second Trading Day immediately prior to the date on which any Placement Notice is delivered to the Placement Agent hereunder and ending on the second Trading Day immediately following the Settlement Date with respect to shares of Common Stock sold pursuant to any such Placement Notice, the Company shall provide the Placement Agent notice before it contracts to sell, sells, grants any option to sell or otherwise disposes of any shares of Common Stock (other than Placement Securities offered pursuant to the provisions of this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire Common Stock; <i>provided</i>, that such notice shall not be required in connection with the (i) issuance, grant or sale of restricted stock, Common Stock, LTIP units, options to purchase Common Stock, or Common Stock issuable upon the exercise of options or other equity awards pursuant to any stock option, stock bonus, employee stock purchase or other stock or compensatory plan or arrangement described in the Prospectus, (ii) the issuance of securities in connection with an acquisition, merger or sale or purchase of assets described in the Prospectus, (iii) issuance of Common Stock or other securities in connection with mergers or acquisitions of business, entities, property or other assets, joint ventures or strategic alliances, (iv) the issuance or sale of Common Stock pursuant to any dividend reinvestment plan that the Company has in effect or may adopt from time to time, <i>provided</i> the implementation of such new plan is disclosed to the Placement Agent in advance&nbsp; (v) the issuance of any Common Stock upon the exchange, conversion or redemption of securities or the exercise of warrants, options, or other rights in effect or outstanding, (v) the issuance of shares of Common Stock or securities exercisable for or convertible into shares of Common Stock as compensation to consultants or service providers, <i>provided </i>that in the case of subsections (iii) and (v) hereof, the aggregate number of shares of Common Stock issued or issuable upon conversion of exchange of securities under subsections (iii) and (v) pursuant to any such arrangement shall not exceed five percent (5%) of the number of shares of Common Stock outstanding immediately prior to giving effect to such issuance. For avoidance of doubt, nothing herein shall be construed to restrict the Company&#8217;s ability, or require the Company to provide notice to the Placement Agent, to file a registration statement with the Commission.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(l) <i>Change of Circumstances</i>. The Company will, at any time during the pendency of a Placement Notice, advise the Placement Agent promptly after it shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect any opinion, certificate, letter or other document provided to the Placement Agent pursuant to this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(m) <i>Due Diligence Cooperation</i>. During the term of this Agreement, the Company will cooperate with any reasonable due diligence review conducted by the Placement Agent or its agents in connection with the transactions contemplated hereby, including, without limitation, providing information and making available documents and senior officers, during regular business hours and at the Company&#8217;s principal offices, as the Placement Agent may reasonably request.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(n) <i>Disclosure of Sales</i>. The Company will, if applicable, disclose in its quarterly reports on Form 10-Q and in its annual report on Form 10-K the number of Placement Securities sold through the Placement Agent during the most recently completed fiscal quarter, the Net Proceeds to the Company and the compensation paid or payable by the Company to the Placement Agent with respect to such Placement Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(o) <i>Representation Dates; Certificate</i>. On the date the Company provides the Placement Agent with the first Placement Notice and subsequently thereafter:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:36pt;">(i) each time the Company files the Prospectus relating to the Placement Securities or amends or supplements the Registration Statement or the Prospectus relating to the Placement Securities (other than amendments or supplements that are filed solely to report sales of the Placement Securities pursuant to this Agreement) by means of a post-effective amendment, sticker, or supplement but not by means of incorporation of documents by reference into the Registration Statement or the Prospectus relating to the Placement Securities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:36pt;">(ii) each time the Company files an annual report on Form 10-K under the Exchange Act;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:36pt;">(iii) each time the Company files its quarterly reports on Form 10-Q under the Exchange Act; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 44pt;text-indent:36pt;">(iv) each time the Company files a report on Form 8-K containing amended financial information (other than an earnings release, to &#8220;furnish&#8221; information pursuant to Items 2.02 or 7.01 of Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to the reclassifications of certain properties as discontinued operations in accordance with Statement of Financial Accounting Standards No. 144) under the Exchange Act (each date of filing of one or more of the documents referred to in clauses (i) through (iv) shall be a &#8220;<u>Representation Date</u>&#8221;);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">the Company shall furnish the Placement Agent with a certificate, in the form attached hereto as <u>Exhibit D</u>, within three (3) Trading Days of any Representation Date if required by the Placement Agent. The requirement to provide a certificate under this Section 7(o) shall be automatically waived for any Representation Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the earlier to occur of the date the Company delivers a Placement Notice hereunder (which for such calendar quarter shall be considered a Representation Date) and the next occurring Representation Date; <i>provided, however</i>, that such waiver shall not apply for any Representation Date on which the Company files its annual report on Form 10-K. Notwithstanding the foregoing, if the Company subsequently decides to sell Placement Securities following a Representation Date when the Company relied on such waiver and did not provide the Placement Agent with a certificate under this Section 7(o), then before the Company delivers the Placement Notice or the Placement Agent sells any Placement Securities, the Company shall provide the Placement Agent with a certificate, in the form attached hereto as <u>Exhibit D</u>, dated the date of the Placement Notice.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(p) <i>Legal Opinions and Negative Assurance Letter</i>. On the date the Company provides the Placement Agent with the first Placement Notice and within five (5) Trading Days after each Representation Date (excluding Representation Dates with regard to the time the Company files its quarterly reports on Form 10-Q) with respect to which the Company is obligated to deliver a certificate in the form attached hereto as <u>Exhibit D</u> for which no waiver is applicable, the Company shall cause to be furnished to the Placement Agent (i) a written opinion and negative assurance letter of Lowenstein Sandler LLP, corporate counsel to the Company (&#8220;<u>Company Corporate Counsel</u>&#8221;), or other counsel satisfactory to the Placement Agent, in form and substance reasonably satisfactory to the Placement Agent and its counsel, dated the date that the opinion is required to be delivered, , and (ii), unless waived by the Placement Agent, a written opinion and negative assurance letter of Ellenoff Grossman &amp; Schole LLP, counsel to the Placement Agent (&#8220;<u>Counsel to the Placement Agent</u>&#8221;), or other counsel reasonably satisfactory to the Placement Agent, in form and substance reasonably satisfactory to the Placement Agent, dated the date that the opinion is required to be delivered; <i>provided, however</i>, that in lieu of such opinions for subsequent Representation Dates, counsel may furnish the Placement Agent with a letter (a &#8220;<u>Reliance Letter</u>&#8221;) to the effect that the Placement Agent may rely on a prior opinion delivered under this Section 7(p) to the same extent as if it were dated the date of such letter (except that statements in such prior opinion shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented at such Representation Date).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(q) <i>Comfort Letter</i>. On the date of the Company provides the Placement Agent with the first Placement Notice and within five (5) Trading Days after each Representation Date (excluding Representation Dates with regard to the time the Company files its quarterly reports on Form 10-Q) with respect to which the Company is obligated to deliver a certificate in the form attached hereto as <u>Exhibit D</u> for which no waiver is applicable, the Company shall cause its independent accountants (and any other independent accountants whose report is included in the Prospectus) to furnish the Placement Agent letters (the &#8220;<u>Comfort Letters</u>&#8221;), dated the date of the Comfort Letter is delivered, in form and substance reasonably satisfactory to the Placement Agent, (i) confirming that they are an independent registered public accounting firm within the meaning of the Securities Act, the Exchange Act and the PCAOB, (ii) stating, as of such date, the conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants&#8217; &#8220;comfort letters&#8221; to underwriters in connection with registered public offerings.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(r) <i>Market Activities</i>. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities or (ii) sell, bid for, or purchase shares of the Securities to be issued and sold pursuant to this Agreement in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Securities to be issued and sold pursuant to this Agreement other than the Placement Agent; <i>provided, however</i>, that the Company may bid for and purchase its Common Stock in accordance with Rule 10b-18 under the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(s) <i>Investment Company Act</i>. The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor its Subsidiaries will be or become, at any time prior to the termination of this Agreement, an &#8220;investment company,&#8221; as such term is defined in the Investment Company Act, assuming no change in the Commission&#8217;s current interpretation as to entities that are not considered an &#8220;investment company&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(t) <i>Securities Act and Exchange Act</i>. The Company will use commercially reasonable&nbsp; efforts to comply with all requirements imposed upon it by the Securities Act and the Exchange Act as from time to time in force, so far as necessary to permit the continuance of sales of, or dealings in, the Placement Securities as contemplated by the provisions hereof and the Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(u) <i>No Offer to Sell</i>. Other than a free writing prospectus (as defined in Rule 405 under the Securities Act) approved in advance in writing by the Company and the Placement Agent in its capacity as principal or agent hereunder, the Company (including its agents and representatives, other than the Placement Agent in its capacity as such) will not, directly or indirectly, make, use, prepare, authorize, approve or refer to any free writing prospectus relating to the Securities to be sold by the Placement Agent as principal or agent hereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(v) <i>Sarbanes-Oxley Act</i>. The Company and its Subsidiaries will use commercially reasonable efforts to comply with all effective applicable provisions of the Sarbanes-Oxley Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 8. <u>Payment of Expenses</u>. The Company will pay all expenses incident to the performance of its obligations under this Agreement, including (i) the preparation, printing and filing of the Registration Statement (including financial statements and exhibits) as originally filed and of each amendment and supplement thereto, (ii) the word processing, printing and delivery to the Placement Agent of this Agreement and such other documents as may be required in connection with the offering, purchase, sale, issuance or delivery of the Placement Securities, (iii) the preparation, issuance and delivery of the certificates for the Placement Securities to the Placement Agent, including any stock or other transfer taxes and any capital duties, stamp duties or other duties or taxes payable upon the sale, issuance or delivery of the Placement Securities to the Placement Agent, (iv) the fees and disbursements of the counsel, accountants and other advisors to the Company, (v) the qualification or exemption of the Placement Securities under securities laws in accordance with the provisions of Section 7(e) hereof, including filing fees and the reasonable fees and disbursements of counsel for the Placement Agent in connection therewith and in connection with the preparation of the Blue Sky Survey and any supplements thereto, (vi) the printing and delivery to the Placement Agent of copies of any permitted Free Writing Prospectus and the Prospectus and any amendments or supplements thereto and any costs associated with electronic delivery of any of the foregoing by the Placement Agent to investors, (vii) the fees and expenses of the transfer agent and registrar for the Securities, (viii) the filing fees incident to, and the reasonable fees and disbursements of counsel to the Placement Agent in connection with, the review by FINRA of the terms of the sale of the Securities, and (ix) the fees and expenses incurred in connection with the listing of the Placement Securities on the Nasdaq, and (x) the reasonable fees and disbursements of counsel for the Placement Agent, including the fees set forth in Subsection (v) and (viii) of this Section 8, which shall not exceed $50,000 in the aggregate in connection with the first Placement Notice, and after the first Placement Notice, up to $5,000 per quarter in a quarter in which a Placement Notice has been given or is in place, in connection with the review and preparation of the deliverables set forth in Sections 7(o), (p) and (q).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 9. <u>Conditions of the Placement Agent</u><u>&#8217;</u><u>s Obligations</u>. The obligations of the Placement Agent hereunder with respect to a Placement will be subject to the continuing accuracy and completeness of the representations and warranties of the Company contained in this Agreement or in certificates of any officer of the Company or any subsidiary of the Company delivered pursuant to the provisions hereof, to the performance by the Company of its covenants and other obligations hereunder, and to the following further conditions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(a) <i>Opinions and Negative Assurance Letter of Company Corporate Counsel and Counsel to the Placement Agent</i>. On the date the Company provides the Placement Agent with the first Placement Notice (i) the Company shall furnish to the Placement Agent the opinion, addressed to the Placement Agent, of&nbsp; the Company Corporate Counsel, or other counsel satisfactory to the Placement Agent, in form and substance reasonably satisfactory to the Placement Agent and its counsel, dated the date that the opinion is required to be delivered and a negative assurance letter; and (ii), unless waived by the Placement Agent, Ellenoff Grossman &amp; Schole LLP, counsel to the Placement Agent, or other counsel satisfactory to the Placement Agent, shall furnish to the Placement Agent the opinion, addressed to the Placement Agent, in form and substance reasonably satisfactory to the Placement Agent dated the date that the opinion is required to be delivered.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(b) <i>Effectiveness of Registration Statement</i>. The Registration Statement and any Rule 462(b) Registration Statement shall have become effective and shall be available for (i) all sales of Placement Securities issued pursuant to all prior Placement Notices and (ii) the sale of all Placement Securities contemplated to be issued by any Placement Notice.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(c) <i>No Material Notices</i>. None of the following events shall have occurred and be continuing: (i) receipt by the Company or any of its Subsidiaries of any request for additional information from the Commission or any other Governmental Authority during the period of effectiveness of the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration Statement or the Prospectus; (ii) the issuance by the Commission or any other Governmental Authority of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Placement Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; or (iv) the occurrence of any event that makes any material statement made in the Registration Statement or the Prospectus, or any Issuer Free Writing Prospectus, or any material document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement, the Prospectus, or any Issuer Free Writing Prospectus, or such documents so that, in the case of the Registration Statement, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, that in the case of the Prospectus and any Issuer Free Writing Prospectus, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(d) <i>No Misstatement or Material Omission</i>. The Placement Agent shall not have advised the Company that the Registration Statement or Prospectus, or any Issuer Free Writing Prospectus, or any amendment or supplement thereto, contains an untrue statement of fact that in the Placement Agent&#8217;s reasonable opinion is material, or omits to state a fact that in the Placement Agent&#8217;s opinion is material and is required to be stated therein or is necessary to make the statements therein not misleading.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(e) <i>Material Changes</i>. Except as contemplated in the Prospectus, or disclosed in the Company&#8217;s reports filed with the Commission, there shall not have been any Material Adverse Effect, whether or not arising in the ordinary course of business.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(f) <i>Representation Certificate</i>. The Placement Agent shall have received the certificate required to be delivered pursuant to Section 7(o) on or before the date on which delivery of such certificate is required pursuant to Section 7(o).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(g) <i>Accountant</i>&#8217;<i>s Comfort Letter</i>. The Placement Agent shall have received the Comfort Letter required to be delivered pursuant Section 7(q) on or before the date on which such delivery of such letter is required pursuant to Section 7(q).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(h) <i>Secretary</i>&#8217;<i>s Certificate</i>. On the date of the Company provides the Placement Agent with the first Placement Notice, the Placement Agent shall have received a certificate, signed on behalf of the Company by its corporate Secretary, in form and substance reasonably satisfactory to the Placement Agent and its counsel</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(i) <i>Approval for Listing</i>. The Placement Securities shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Securities on Nasdaq at, or prior to, the issuance of any Placement Notice.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(j) <i>No Suspension</i>. Trading in the Securities shall not have been suspended on the Nasdaq.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(k) <i>Additional Documents</i>. On each date on which the Company is required to deliver a certificate pursuant to Section 7(o), counsel for the Placement Agent shall have been furnished with such documents and opinions as they shall have reasonably requested for the purpose of enabling them to pass upon the issuance and sale of the Securities as herein contemplated, or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the conditions, contained in this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(l) <i>Securities Act Filings Made</i>. All filings with the Commission required by Rule 424 under the Securities Act to have been filed prior to the issuance of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424 under the Securities Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(m) <i>Termination of Agreement</i>. If any condition specified in this Section 9 shall not have been fulfilled when and as required to be fulfilled, this Agreement may be terminated by the Placement Agent by notice to the Company, and such termination shall be without liability of any party to any other party except as provided in Section 7 hereof and except that, in the case of any termination of this Agreement, Sections 5, 10, 11 and 19 hereof shall survive such termination and remain in full force and effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 10. <u>Indemnity and Contribution by the Company and the Placement Agent.</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(a) <i>Indemnification by the Company</i>. The Company agrees to indemnify, defend and hold harmless the Placement Agent and any person who controls the Placement Agent within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any loss, expense, liability, damage or claim (including the reasonable cost of investigation) which, jointly or severally, the Placement Agent or any controlling person may incur under the Securities Act, the Exchange Act or otherwise, insofar as such loss, expense, liability, damage or claim arises out of or is based upon (1) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereof), any Issuer Free Writing Prospectus that the Company has filed or was required to file with the Commission or the Prospectus (the term Prospectus for the purpose of this Section 10 being deemed to include the Prospectus as of its date and as amended or supplemented by the Company), (2) any omission or alleged omission to state a material fact required to be stated in any such Registration Statement, or necessary to make the statements made therein not misleading, or (3) any omission or alleged omission from any such Issuer Free Writing Prospectus or Prospectus of a material fact necessary to make the statements made therein, in the light of the circumstances under which they were made, not misleading; <i>except</i>, in the case of each of clauses (1), (2) and (3), insofar as any such loss, expense, liability, damage or claim arises out of or is based upon any untrue statement or alleged untrue statement of a material fact or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of the Prospectus and any Issuer Free Writing Prospectus, in the light of the circumstances under which they were made) not misleading, in each such case, to the extent contained in and in conformity with information furnished in writing the Placement Agent to the Company expressly for use therein (that information being limited to that described in Section 10(b) hereof). The indemnity agreement set forth in this Section 10(a) shall be in addition to any liability which the Company may otherwise have. If any action is brought against the Placement Agent or any controlling person in respect of which indemnity may be sought against the Company pursuant to the foregoing paragraph of this Section 10(a), the Placement Agent shall promptly notify the Company, as the case may be, in writing of the institution of such action, and the Company, as the case may be, shall if it so elects, assume the defense of such action, including the employment of counsel and payment of expenses; <i>provided</i>, <i>however</i>, that any failure or delay to so notify the Company, as the case may be, will not relieve the Company of any obligation hereunder, except to the extent that their ability to defend is materially prejudiced by such failure or delay. The Placement Agent or such controlling person shall have the right to employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of the Placement Agent or such controlling person unless the employment of such counsel shall have been authorized in writing by the Company, as the case may be, in connection with the defense of such action, or the Company shall not have employed counsel reasonably satisfactory to the Placement Agent or such controlling person, as the case may be, to have charge of the defense of such action within a reasonable time or such indemnified party or parties shall have reasonably concluded (based on the advice of counsel) that there may be defenses available to it or them which are different from or additional to those available to the Company (in which case neither the Company shall have the right to direct the defense of such action on behalf of the indemnified party or parties), in any of which events such fees and expenses shall be borne by the Company and paid as incurred (it being understood, however, that neither the Company shall be liable for the expenses of more than one separate firm of attorneys for the Placement Agent or such controlling persons in any one action or series of related actions in the same jurisdiction (other than local counsel in any such jurisdiction) representing the indemnified parties who are parties to such action). Anything in this paragraph to the contrary notwithstanding, the Company shall not be liable for any settlement of any such claim or action effected without its written consent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(b) <i>Indemnification by the Placement Agent. </i>The Placement Agent agrees to indemnify, defend and hold harmless the Company, the Company&#8217;s directors, the Company&#8217;s officers that signed the Registration Statement, and any person who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any loss, expense, liability, damage or claim (including the reasonable cost of investigation) which, jointly or severally, the Company or any such person may incur under the Securities Act, the Exchange Act or otherwise, insofar as such loss, expense, liability, damage or claim arises out of or is based upon (1) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereof), any Issuer Free Writing Prospectus that the Company has filed or was required to file with the Commission, the Prospectus, (2) any omission or alleged omission to state a material fact required to be stated in any such Registration Statement, or necessary to make the statements made therein not misleading, or (3) any omission or alleged omission from any such Issuer Free Writing Prospectus or the Prospectus of a material fact necessary to make the statements made therein, in the light of the circumstances under which they were made, not misleading, but in each case only insofar as such untrue statement or alleged untrue statement or omission or alleged omission was made in such Registration Statement, Issuer Free Writing Prospectus or Prospectus in reliance upon and in conformity with information furnished in writing by the Placement Agent to the Company expressly for use therein. The statements set forth under the caption &#8220;Plan of Distribution&#8221; in the Prospectus Supplement (to the extent such statements relate to the Placement Agent) constitute the only information furnished by or on behalf of the Placement Agent to the Company for the purposes of Section 5(a)(1) and this Section 10. The indemnity agreement set forth in this Section 10(b) shall be in addition to any liabilities that the Placement Agent may otherwise have.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">If any action is brought against the Company or any such person in respect of which indemnity may be sought against the Placement Agent pursuant to the foregoing paragraph, the Company or such person shall promptly notify the Placement Agent in writing of the institution of such action and the Placement Agent shall if it so elects assume the defense of such action, including the employment of counsel and payment of expenses; <i>provided</i>, <i>however</i>, that any failure or delay to so notify the Placement Agent will not relieve the Placement Agent of any obligation hereunder, except to the extent that their ability to defend is materially prejudiced by such failure or delay. The Company or such person shall have the right to employ its own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of the Company or such person unless the employment of such counsel shall have been authorized in writing by the Placement Agent in connection with the defense of such action or the Placement Agent shall not have employed counsel reasonably satisfactory to the Company or such person, as the case may be, to have charge of the defense of such action within a reasonable time or such indemnified party or parties shall have reasonably concluded (based on the advice of counsel) that there may be defenses available to it or them which are different from or additional to those available to (in which case the Placement Agent shall not have the right to direct the defense of such action on behalf of the indemnified party or parties), in any of which events such fees and expenses shall be borne by the Placement Agent and paid as incurred (it being understood, however, that the Placement Agent shall not be liable for the expenses of more than one separate firm of attorneys in any one action or series of related actions in the same jurisdiction (other than local counsel in any such jurisdiction) representing the indemnified parties who are parties to such action). Anything in this paragraph to the contrary notwithstanding, the Placement Agent shall not be liable for any settlement of any such claim or action effected without its written consent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(c) <i>Contribution</i>. If the indemnification provided for in this Section 10 is unavailable or insufficient to hold harmless an indemnified party under subsections (a) and (b) of this Section 10 in respect of any losses, expenses, liabilities, damages or claims referred to therein, then each applicable indemnifying party, in lieu of indemnifying such indemnified party, shall contribute to the amount paid or payable by such indemnified party as a result of such losses, expenses, liabilities, damages or claims (i) in such proportion as is appropriate to reflect the relative benefits received by the Company and by the Placement Agent, each from the offering of the Securities, or (ii) if (but only if) the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company and the Placement Agent in connection with the statements or omissions which resulted in such losses, expenses, liabilities, damages or claims, as well as any other relevant equitable considerations. The relative benefits received by the Company shall be deemed to be equal to the net proceeds from the offering of Securities (after deducting discounts and expenses) received by it and benefits received by the Placement Agent shall be deemed to be equal to the underwriting discounts and commissions received by the Placement Agent. The relative fault of the Company and of the Placement Agent shall be determined by reference to, among other things, whether the untrue statement or alleged untrue statement of a material fact or omission or alleged omission relates to information supplied by the Company or by the Placement Agent and the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The amount paid or payable by a party as a result of the losses, claims, damages and liabilities referred to above shall be deemed to include any legal or other fees or expenses reasonably incurred by such party in connection with investigating or defending any claim or action.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(d) The Company and the Placement Agent agree that it would not be just and equitable if contribution pursuant to this Section 10 were determined by <i>pro rata</i> allocation or by any other method of allocation which does not take account of the equitable considerations referred to in clause (i) and, if applicable, clause (ii) of subsection (c) above. Notwithstanding the provisions of this Section 10, the Placement Agent shall not be required to contribute any amount in excess of the underwriting discounts and commissions applicable to the Securities purchased by the Placement Agent and the liability of the Company pursuant to this Section 10 shall not exceed the gross proceeds received by the Company in the offering. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(e) The provisions of this Section shall not affect any agreement among the Company with respect to indemnification.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 11. <u>Representations, Warranties and Agreements to Survive Delivery</u>. All representations, warranties and agreements contained in this Agreement or in certificates of officers of the Company or any of its Subsidiaries submitted pursuant hereto, shall remain operative and in full force and effect, regardless of any investigation made by or on behalf of the Placement Agent or controlling person, or by or on behalf of the Company, and shall survive delivery of the Securities to the Placement Agent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 12. <u>Termination of Agreement</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(a) <i>Termination; General</i>. The Placement Agent may terminate this Agreement, by notice to the Company, as hereinafter specified at any time (i) if there has been, since the time of execution of this Agreement or since the date as of which information is given in the Prospectus, any Material Adverse Effect, whether or not arising in the ordinary course of business, or (ii) if there has occurred any material adverse change in the financial markets in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or development involving a prospective change in national or international political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of the Placement Agent, impracticable or inadvisable to market the Securities or to enforce contracts for the sale of the Securities, or (iii) if trading in the Placement Securities has been suspended or limited by the Commission or the Nasdaq, or if trading generally on the American Stock Exchange, the Nasdaq or the New York Stock Exchange has been suspended or limited, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices have been required, by any of said exchanges or by order of the Commission, the FINRA or any other Governmental Authority, or a material disruption has occurred in commercial banking or securities settlement or clearance services in the United States or in Europe, or (iv) if a banking moratorium has been declared by either Federal or New York authorities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(b) <i>Termination by the Company</i>. The Company shall have the right, by giving one (1) day notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement. Upon termination of this Agreement pursuant to this Section 12(b), any outstanding Placement Notices shall also be terminated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(c) <i>Termination by the Placement Agent. </i>The Placement Agent shall have the right, by giving one (1) day notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(d) <i>Automatic Termination.</i> Unless earlier terminated pursuant to this Section, this agreement shall automatically terminate upon the issuance and sale of all of the Placement Securities through the Placement Agent on the terms and subject to the conditions set forth herein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(e) <i>Continued Force and Effect</i>. This Agreement shall remain in full force and effect unless terminated pursuant to Sections 12(a), (b), (c) or (d) above or otherwise by mutual agreement of the parties.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(f) <i>Effectiveness of Termination</i>. Any termination of this Agreement shall be effective on the date specified in such notice of termination; <i>provided</i>, <i>however</i>, that such termination shall not be effective until the close of business on the date of receipt of such notice by the Placement Agent or the Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Placement Securities, such Placement Securities shall settle in accordance with the provisions of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(g) <i>Liabilities</i>. If this Agreement is terminated pursuant to this Section 12, such termination shall be without liability of any party to any other party except as provided in Section 8 hereof, and except that, in the case of any termination of this Agreement, Section 5, Section 10, Section 11, Section 16, Section 17, and Section 22 hereof shall survive such termination and remain in full force and effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 13. <u>Notices</u>. Except as otherwise provided in this Agreement, all notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted by any standard form of telecommunication. Notices to the Placement Agent shall be directed to the Placement Agent at JMP Securities LLC, 600 Montgomery Street, 11<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup> Floor, San Francisco, California 94111, Facsimile: (415) 835-8920, Attention: Equity Securities with a copy to Ellenoff Grossman &amp; Schole LLP, 1345 Avenue of the Americas, New York, New York 10145, Facsimile: (212) 401-4741, Attention: Matthew Bernstein, and notices to the Company shall be directed to it at the offices of the Company at 3300 Bee Cave Road, Suite 650-227, Austin Texas 78746, email: rconfer@genprex.com, Attention Ryan Confer with a copy to Lowenstein Sandler LLP, 1251 Avenue of the Americas, New York, NY 10020, e-mail: kbasmagian@lowenstein.com, Attention: Kate Basmagian, Esq..</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 14. <u>Parties</u>. This Agreement shall inure to the benefit of and be binding upon the Placement Agent, the Company and their respective successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, firm or corporation, other than the Placement Agent, the Company and their respective successors and the controlling persons and officers and directors referred to in Section 10 and their heirs and legal representatives, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision herein contained. This Agreement and all conditions and provisions hereof are intended to be for the sole and exclusive benefit of the Placement Agent, the Company and their respective successors, and said controlling persons and officers and directors and their heirs and legal representatives, and for the benefit of no other person, firm or corporation. No purchaser of Securities from the Placement Agent shall be deemed to be a successor by reason merely of such purchase.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 15. <u>Adjustments for Stock Splits</u>. The parties acknowledge and agree that all stock-related numbers contained in this Agreement shall be adjusted to take into account any stock split, stock dividend or similar event effected with respect to the Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 16. <u>Governing Law and Time</u>. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICT OF LAWS. SPECIFIED TIMES OF DAY REFER TO EASTERN TIME. EACH PARTY HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 17. <u>Consent to Jurisdiction</u>. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH ANY TRANSACTION CONTEMPLATED HEREBY, AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR THAT THE VENUE OF SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF (CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. TO THE EXTENT THAT THE COMPANY HAS OR HEREAFTER MAY ACQUIRE ANY IMMUNITY (ON THE GROUNDS OF SOVEREIGNTY OR OTHERWISE) FROM THE JURISDICTION OF ANY COURT OR FROM ANY LEGAL PROCESS WITH RESPECT TO ITSELF OR ITS PROPERTY, THE COMPANY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, SUCH IMMUNITY IN RESPECT OF ANY SUCH SUIT, ACTION OR PROCEEDING.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 18. <u>Effect of Headings</u>. The Section and Exhibit headings herein are for convenience only and shall not affect the construction hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 19. <u>Permitted Free Writing Prospectuses</u>. The Company represents, warrants and agrees that, unless it obtains the prior consent of the Placement Agent, which consent shall not be unreasonably withheld, conditioned or delayed, and the Placement Agent represents, warrants and agrees that, unless it obtains the prior consent of the Company, which consent shall not be unreasonably withheld, conditioned or delayed, it has not made and will not make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus, or that would otherwise constitute a &#8220;free writing prospectus,&#8221; as defined in Rule 405 under the Securities Act, required to be filed with the Commission. Any such free writing prospectus consented to by the Placement Agent or by the Company, as the case may be, is hereinafter referred to as a &#8220;Permitted Free Writing Prospectus.&#8221; The Company represents and warrants that it has treated and agrees that it will treat each Permitted Free Writing Prospectus as an &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433 under the Securities Act, and has complied and will comply with the requirements of Rule 433 under the Securities Act applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping. For the purposes of clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Exhibit E hereto, as modified from time to time, are Permitted Free Writing Prospectuses.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">SECTION 20. <u>Absence of Fiduciary Relationship</u>. The Company acknowledges and agrees that:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(a) The Placement Agent is acting solely as agent and/or principal in connection with the public offering of the Securities and in connection with each transaction contemplated by this Agreement and the process leading to such transactions, and no fiduciary or advisory relationship between the Company or any of its respective affiliates, stockholders (or other equity holders), creditors or employees or any other party, on the one hand, and the Placement Agent and its affiliates, on the other hand, has been or will be created in respect of any of the transactions contemplated by this Agreement, irrespective of whether or not the Placement Agent has advised or is advising the Company on other matters, and the Placement Agent has no obligation to the Company with respect to the transactions contemplated by this Agreement except the obligations expressly set forth in this Agreement;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(b) the public offering price of the Securities was not established by the Placement Agent; it is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions contemplated by this Agreement;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(c) neither the Placement Agent nor its affiliates has provided any legal, accounting, regulatory or tax advice with respect to the transactions contemplated by this Agreement and it has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(d) it is aware that the Placement Agent and its respective affiliates are engaged in a broad range of transactions which may involve interests that differ from those of the Company and the Placement Agent and its affiliates have no obligation to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship or otherwise; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">(e) it waives, to the fullest extent permitted by law, any claims it may have against the Placement Agent or its affiliates for breach of fiduciary duty or alleged breach of fiduciary duty and agrees that neither the Placement Agent nor its affiliates shall have any liability (whether direct or indirect, in contract, tort or otherwise) to it in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on its behalf or in right of it or the Company, employees or creditors of Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">SECTION 21. <u>Counterparts</u>. This Agreement may be executed in two or more counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument, and may be delivered by facsimile transmission or by electronic delivery of a portable document format (PDF) file (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">SECTION 22. <u>Entire Agreement; Amendment; Severability; Waiver</u>. This Agreement (including all schedules and exhibits attached hereto and Placement Notices issued pursuant hereto) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed by the Company and the Placement Agent. The Section headings herein are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement. In the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement. No implied waiver by a party shall arise in the absence of a waiver in writing signed by such party. No failure or delay in exercising any right, power, or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any right, power, or privilege hereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">[<i>Signature Page Follows</i>]</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">If the foregoing is in accordance with your understanding of our agreement, please sign and return to the Company a counterpart hereof, whereupon this instrument, along with all counterparts, will become a binding agreement by and between the Placement Agent and the Company in accordance with its terms.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td colspan="3" style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Very truly yours,</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td colspan="3" style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td colspan="3" style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>GENPREX, INC.</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td colspan="3" style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td colspan="3" style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>/s/ Catherine Vaczy</i></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name:</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Catherine Vaczy</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title:</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Executive Vice President, General Counsel and Chief Strategy Officer</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td colspan="4" style="vertical-align: top; width: 14%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CONFIRMED AND ACCEPTED, as of the date first above written:</p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 86%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>JMP SECURITIES LLC</b></p>
			</td>
			<td style="vertical-align: top; width: 86%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 86%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 0%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align: top; width: 5%;">By:</td>
			<td style="vertical-align: top; width: 9%;"><i>/s/ James Alfaro</i></td>
			<td style="vertical-align: top; width: 86%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 0%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 9%;">Name:</td>
			<td style="vertical-align: top; width: 86%;">James Alfaro</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 0%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 9%;">Title:</td>
			<td style="vertical-align: top; width: 86%;">Managing Director</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 0%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 9%;">&nbsp;</td>
			<td style="vertical-align: top; width: 86%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">Signature Page to Equity Distribution Agreement</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">EXHIBIT A</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><u>FORM OF PLACEMENT NOTICE</u></p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">From:</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">[ ]</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cc:</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">[ ]</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To:</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">[ ]</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Subject: Equity Distribution&#8212;Placement Notice</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Ladies and Gentlemen:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between Genprex, Inc. (the &#8220;<u>Company</u>&#8221;) and JMP Securities LLC (the &#8220;<u>Placement Agent</u>&#8221;) dated November [_], 2022 (the &#8220;<u>Agreement</u>&#8221;), I hereby request on behalf of the Company that the Placement Agent sell up to [[ ] shares or $[_]] of the Company&#8217;s common stock, par value $0.001 per share, at a minimum market price of $[ ] per share.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">[ADDITIONAL SALES PARAMETERS MAY BE ADDED, SUCH AS THE MAXIMUM AGGREGATE OFFERING PRICE, THE TIME PERIOD IN WHICH SALES ARE REQUESTED TO BE MADE, SPECIFIC DATES THE SHARES MAY NOT BE SOLD ON, THE MANNER IN WHICH SALES ARE TO BE MADE BY THE PLACEMENT AGENT, AND/OR THE CAPACITY IN WHICH THE PLACEMENT AGENT MAY ACT IN SELLING SHARES (AS PRINCIPAL, AGENT, OR BOTH)]</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">EXHIBIT B</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><u>AUTHORIZED INDIVIDUALS FOR PLACEMENT NOTICES AND ACCEPTANCES</u><b> </b></p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><u>JMP Securities LLC</u></b></p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Name</u></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Andrew Mertz, Managing&nbsp;Director</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jim Alfaro, Managing Director</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Danny Matthews, Director</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">John Pitarresi, Managing Director</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Aidan&nbsp;Whitehead, Managing Director</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Julian Carlson, Director</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Email</u></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">amertz@jmpsecurities.com</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">jalfaro@jmpsecurities.com</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">dmatthews@jmpsecurities.com</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">JPitarresi@jmpsecurities.com</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">awhitehead@jmpsecurities.com</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">jcarlson@jmpsecurities.com</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><u>Genprex, Inc.</u></b></p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Name</u></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Rodney Varner</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Catherine Vaczy</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ryan Confer</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Email</u></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">rvarner@genprex.com</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">cvaczy@genprex.com</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">rconfer@genprex.com</p>
			</td>
		</tr>

</table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">EXHIBIT C</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><u>COMPENSATION</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Placement Agent shall be paid compensation equal to 3.0% of the gross proceeds from the sales of Securities pursuant to the terms of this Agreement.</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">EXHIBIT D</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><u>OFFICER CERTIFICATE</u></p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">EXHIBIT E</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><u>ISSUER FREE WRITING PROSPECTUSES</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><u>None.</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ex_449034.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html><head>
	<title>HTML Editor</title>
	<meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; padding:0in .1in;">
<div>&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>Exhibit 5.1</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">November 18, 2022</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Genprex, Inc.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">3330 Bee Cave Road, #650-227</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Austin, TX 78746</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Re:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sale of Common Stock registered pursuant to Shelf Registration Statement on Form S-3</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Ladies and Gentlemen:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">We have acted as counsel to Genprex, Inc., a Delaware corporation (the &#8220;<b>Company</b>&#8221;), in connection with the offer and sale by the Company of up to an aggregate of $50,000,000 of shares of its common stock, par value $0.001 per share (the &#8220;<b>Shares</b>&#8221;), pursuant to the Equity Distribution Agreement (the &#8220;<b>Sales Agreement</b>&#8221;), dated November 18, 2022, by and between the Company and JMP Securities, LLC, as sales agent.&nbsp; The Shares are being offered for sale pursuant to the Company&#8217;s registration statement on Form S-3 (File No. 333-239134) filed with the Securities and Exchange Commission (the &#8220;<b>Commission</b>&#8221;) pursuant to the Securities Act of 1933, as amended (the &#8220;<b>Securities Act</b>&#8221;)&nbsp; and the rules and regulations promulgated thereunder, the prospectus, dated July 17, 2020 (the &#8220;<b>Prospectus</b>&#8221;) and the Prospectus Supplement that will be filed pursuant to Rule 424(b) under the Securities Act, dated November 18, 2022 (the &#8220;<b>Prospectus Supplement</b>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">We understand that the Shares are to be issued by the Company and sold by JMP Securities, LLC pursuant to the Sales Agreement, as described in the Registration Statements, the Prospectus and the Prospectus Supplement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">In connection with this opinion, we have (i) investigated such questions of law, (ii) examined originals or certified, conformed or reproduction copies of such agreements, instruments, documents and records of the Company, such certificates of public officials and such other documents and (iii) received such information from officers and representatives of the Company as we have deemed necessary or appropriate for the purposes of this opinion.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">In all such examinations, we have assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of original and certified documents and the conformity to original or certified documents of all copies submitted to us as conformed or reproduction copies. As to various questions of fact relevant to the opinion expressed herein, we have relied upon, and assume the accuracy of, the representations and warranties set forth in the Sale Agreement, and certificates and oral or written statements and other information of or from public officials and officers and representatives of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Based upon the foregoing and subject to the limitations, qualifications and assumptions set forth herein, we are of the opinion that the Shares have been duly authorized for issuance, and when issued and paid for in accordance with the terms and conditions of the Sales Agreement, the Shares will be validly issued, fully paid and non-assessable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The opinion expressed herein is limited to the applicable provisions of the General Corporation Law of the State of Delaware (the &#8220;<b>DGCL</b>&#8221;), as currently in effect, and reported judicial decisions interpreting such provisions of the DGCL.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The opinion expressed herein is limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated herein. We undertake no obligation to supplement this letter if any applicable laws change after the date hereof or if we become aware of any facts that might change the opinion expressed herein after that date or for any other reason.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">We hereby consent to the inclusion of this opinion as Exhibit 5.1 to the Current Report on Form 8-K filed by the Company on the date hereof and which is incorporated by reference into the Prospectus and to the references to this firm under the caption &#8220;Legal Matters&#8221; in the Prospectus Supplement. In giving these consents, we do not admit that we are &#8220;experts&#8221; within the meaning of Section 11 of the Securities Act or within the category of persons whose consent is required by Section 7 of the Securities Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Very truly yours,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>/s/ Lowenstein Sandler</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Lowenstein Sandler LLP</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; margin: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>gnpx-20221118.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/18/2022 8:45:27 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:gnpx="http://www.gnpx.com/20221118" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.gnpx.com/20221118">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gnpx-20221118_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gnpx-20221118_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gnpx-20221118_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.gnpx.com/20221118/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="gnpx_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>gnpx-20221118_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/18/2022 8:45:27 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.gnpx.com/20221118/role/statement-document-and-entity-information" xlink:href="gnpx-20221118.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.gnpx.com/20221118/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>gnpx-20221118_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/18/2022 8:45:27 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" xlink:type="locator"/>
<link:label xlink:label="dei_EntityExTransitionPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Ex Transition Period</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>gnpx-20221118_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/18/2022 8:45:27 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.gnpx.com/20221118/role/statement-document-and-entity-information" xlink:href="gnpx-20221118.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.gnpx.com/20221118/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140672052032080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 18, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">GENPREX, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Nov. 18,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-38244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">90-0772347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">3300 Bee Cave Road, #650-227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Austin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">78746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">537-7997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GNPX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity, Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001595248<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>gnpx20221118_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gnpx-20221118.xsd" xlink:type="simple"/>
    <context id="d20228K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001595248</identifier>
        </entity>
        <period>
            <startDate>2022-11-18</startDate>
            <endDate>2022-11-18</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20228K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20228K">0001595248</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20228K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20228K">2022-11-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20228K">GENPREX, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20228K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20228K">001-38244</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20228K">90-0772347</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20228K">3300 Bee Cave Road, #650-227</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20228K">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20228K">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20228K">78746</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20228K">512</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20228K">537-7997</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20228K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20228K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20228K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20228K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20228K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20228K">GNPX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20228K">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20228K">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="d20228K">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
MP()R56T=H A>!   +A$  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R5
MF&N/XC84AO^*E96J5H(A,?<I(#$,,T6[R]*!=E>M^L$D!JQ)XM1QN/S['B>0
M4&TX8;^0F\^;)\?'KVT&!ZG>XQWGFAP#/XR'UD[KZ+'1B-T=#UC\(",>PI.-
M5 '3<*FVC3A2G'EI4. WJ&UW&@$3H34:I/<6:C20B?9%R!>*Q$D0,'5ZXKX\
M#"W'NMQX$]N=-C<:HT'$MGS)]1_10L%5(U?Q1,##6,B0*+X96F/G\8FV34#:
MXD_!#_'5.3&?LI;RW5S,O*%E&R+N<U<;"0:'/9]PWS=*P/'O6=3*WVD"K\\O
MZB_IQ\/'K%G,)]+_*CR]&UH]BWA\PQ)?O\G#;_S\02F@*_TX_26'K&VK;1$W
MB;4,SL% $(@P.[+C.1%7 ;1_(X"> VC*G;THI7QFFHT&2AZ(,JU!S9RDGYI&
M YP(3:\LM8*G N+TZ%FZ"219DW'HD6FHA3Z169CU-F1MT-#P$M.TX9X%GS)!
M>D-P+O</Q.G5"+4I_7]X ]AR0)H#TE2O605X147^_@2MR$SS(/ZG##&3;)5+
MFD)_C"/F\J$%E1QSM>?6Z*</3L?^%0%NYL!-3'V4);%&WOA6Q%HQ0)^S@)=A
MXD*OT_GB;?JM1F;SR0,"ULK!6JC>)9,ULCI%I3QX?*_^$:%HYQ3M.RD67 EI
MBLXC4+JE0+A47FI5M=;)V3IW==TL=*6*I$J+K4:6&O"(5&0BDU"K$QR]4EQ<
M_7F*('9SQ.Y=B"_"YV2>!&NNRDAP$=MVZLT>;;40H%X.U+L+:,6.9.9!QXJ-
M<+-1>AL/E^S;=;O;I<U6%^'KYWS]N_C&G@=C/<Y/2&HA7\+2CL0EFTW;)D^<
MDPG;<_(FF5<C'SIMNTXI1NS8A2?;/\8\,;8,!;B2AW)+QO7&,(^($$.[FBZ<
M'T/+!\="R;T(W=)\5HBNOF%LQ4SAH+[^/=M"QIKYY"\1W1RR%9+=7K?5P>"*
M6<'!W3SMPC$LG&ZCX )M![,XIY@%'-S&/TD7<K+8R1 SD J1=K-;[_;[:+D7
M,X*#^_A7);3F(20F")+P[!YQ*14NM&%^S#&D8B)P<*]>2E^X @;-EGR&^E:"
M^:4\N$HE3^'Z#N[8"\7K+J2'PP!+5T,K'GI<D2^;S8W^P_4JR0K[=W"S_HYL
M%L<)D%4"XK*5@(7_.[A;KX2&J5)NB$-_7O]"EMQ-H-Y.I4RXDJE/F-:66KKO
MV,JV\'F*^_)*,<^4V/(4K&5I@54(O,X7F'72PM8I[L"7K)#IT=VQ<,MOKEDK
MA.;CY?/X=XSI:N%_GYU/ ZZV)DVO(*%WQB8B%I9V8(6B5@E64[0P<WK?&G]Z
M)-"'L$5-USO9@K:4"Y>KXBJ\G>*V/(81Z*6C\,5GVU(27*!JV-'"U"GNQ9<4
M38!&P80S SLXDH^\O-]P+1L6K.U^F[9Z96B-J]VO^2?A,S/E$A.?;T#-?NB"
MN,HVY]F%EE&Z(5Y+#=OK]'3'&;B5:0#/-U+JRX798^=_D8S^ U!+ P04
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M2>C@W(-@[^&5C!W-CQ]W]P-02P,$%     @ P()R520>FZ*M    ^ $  !H
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M_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%
M  @ P()R50=!36*!    L0   !               ( !     &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    " # @G)5M0PRG^T    K @  $0
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M<R\N<F5L<U!+ 0(4 Q0    ( ,""<E4ZJJ+G0 $  #P"   /
M  "  640  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " # @G)5)!Z;HJT
M  #X 0  &@              @ '2$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " # @G)599!YDAD!  #/ P  $P
M@ &W$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   !%
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="gnpx20221118_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gnpx.com/20221118/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="gnpx20221118_8k.htm">gnpx20221118_8k.htm</File>
    <File>ex_449033.htm</File>
    <File>ex_449034.htm</File>
    <File>gnpx-20221118.xsd</File>
    <File>gnpx-20221118_def.xml</File>
    <File>gnpx-20221118_lab.xml</File>
    <File>gnpx-20221118_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "gnpx20221118_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "gnpx-20221118_def.xml"
     ]
    },
    "inline": {
     "local": [
      "gnpx20221118_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "gnpx-20221118_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gnpx-20221118_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "gnpx-20221118.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 27,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "gnpx",
   "nsuri": "http://www.gnpx.com/20221118",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gnpx20221118_8k.htm",
      "contextRef": "d20228K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.gnpx.com/20221118/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gnpx20221118_8k.htm",
      "contextRef": "d20228K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity, Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.gnpx.com/20221118/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001437749-22-027745-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-22-027745-xbrl.zip
M4$L#!!0    ( ,""<E56 97EVI8  ,IR P -    97A?-#0Y,#,S+FAT;>R]
M:W/;2)(N_/GLKT#,.;M'BH UENV^NK<CU+[TZ(S;]MJ>=_;$&^\'D 0EM$F
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M&P#VG^MQ6AS-95%?4-X&']BL^ZX'H<<QE[^M$?/9^<6/Y!>^W\#/[34\.$.
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MW]U^SK31?B7]C9&<5+YE5<))HD-&$MG4Y) L&W!^$#R KP=#+CV:+G%PV'_
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M@9S\;JLLU9:\\;A6(:^FTT0>9>S*L<"TAGNTUH3@;<ZD\V%V3]%))T=T"&S
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MGF7IL=P:HG5!T06:(T\L;N0\,H[NL33_( [)PGRDLFUCTG+.I:Q-2]OA)V3
M*:R'.\2RH0Y//@;OG8BIP"W)#2G##E%G,8+^''Z+1@]%Q?F,%$YM/2VZ?[R'
M1?^I6?2P@"]>O$:O!!N[P.&CMM^^9/83Z#8#4+=-6P+*1\$=8F0U<02Q $5P
M.5SV0J-D6+G.LC!)7:T)#?LBW&$^[C ?=YB/CU(NWVKH94O5.G4Q[[!9D^_?
M%K>K4!U@B:"2^B41ES5.O0=5.S[C?6*Z 3<L>D*HNK9 VCCC<E4NFI6[9SS<
M<[\PWEX!A(@66[UKF4B#V("B99PMEW!XS@)%4PX&1EU<Y7U1&CZ)OV%>6R('
M@3L!X2T!FI7J()B,@DBM(IC]>&;?HR=ME2$^&Z9HRWQP%\<JR-$2X,K*]'LM
MH].GF+P%9VH1KD04/=I=W%3PCV>.#2!W_ "4OHQ'6X<5^T,6@$2HO[:>64SU
M=8B6#H/=GX8L[3%UGH1(?7]W<2JZ<094$11#_^Z[% QHK0_:V'QP/TZVA9U!
M*;VS,^FVA3]G-!\G"#DEA0CK$H2O("";#+!L<GJHQFW2!_CR)!=BJ,=\K,9\
M46H)N9_A=MX_2CTA@;EC 93QW' <AA=HOWZI@8JU7X_4TQB0_Q E_#1=K)92
M,^,M;T-2567Y]=2J]"'3T46"SLH 09)/[!I1:0GM6UB?HIU8E.Z+WY(GF%OO
M>>K6G#E;*9*S*(O6L;=*M)AK,$W]8ZZRZJ\@?_"H8C)W%ZR6LF1;.N)& BBY
M+$D $]0_X)%-'G"UEN!9+GZ%KR+\HA?I6Y<ZAY6]OEKP5M7'[A@>XIEBV!G7
MOXS<TBXA,.@6[:H)J5U4@I?\).A]^"X "!J18])623WZ\\KP6 QWP"XM)#<C
MX1!]2^XDLZF9QT4 O&B<N<*M)LQH\OOH14KKKGD&[CE@WQ<#&VW?F7 L64'-
MJP49J8!+=^;D(/LGO:21GIC5L>!,MG\=W@5M(-AE@672 )6YAB;26[!N[E+!
M)HUA[F7?JM?MLC^5=@/Y7M:U&'R)</):/*7<*W:E!]!J5U)F(6T*J9)MX@<J
MQQ5K6'J]F5.2UD[&>8CG^&%L_8&E@=592EX.^OX7T+4K"8^G^<]1T9/8C;.&
MD;Z5<D[2M%5G)=-7G5T6-MHX\W]84M^2<>^<VS\UELVC"^9"CIR?BDHS=Q57
M_))>B=%- L^?%U.L6D.4!/Z%;T%ZF[D/4\?]$,5J@. +G8IA)?-N_$@Q1VPR
M19XPWA-Q(3NNR<(T0)NTS?NRU>I27W<Z*V'+W.\3^2"!NYD"^%C!Y<J#X44\
MC'+TEVVSOK@$74]BLD3D!ME9U'23K7\JN&\6G1:4T&QI'<"N:Z:585(=@4J?
M(<8:L;LZQI\V]VP5K<][GM<SV,C6==5#R-R91\:=U],3FWZFTE>;?N8 "A/T
MP>W7+JDT'3]UB/+-^#7BO4>"(_05Z8:ROL1<_CKU?^5:"1#7DN)0TW)X-4I?
MZ2VQ#:[5AS\9B .&6]>TI[;E2^[K^LUG4TUA]K6HU2%(/8.OWT.4!L88O*MZ
M+I-Z+10VP\MRI%H2S#!B^<4_PXO?E\SHT=,#,6,/CAUX2BM^/&X]7(,+1Y6C
MW9+87Z,G]3H6_# '6I)?:*YK%SM81OSS"7\2'B;<.@/?$0'5Y&I:XAU+MZ,T
M/'E (^G)I 1^7#+,N9*&03R1(P]&6VSB=A'/S$NLQG(5DO0@^ZG,-6?<DFD@
MR^,3\"6Q.<MHI\%.,,GU'J'P"GMG+5RMJY!C.U.JV$:&D^^DOVG: 7?I48A)
M5[^W-^S6^^'P2BV(+=K>-8M%7T1VAY(W7R"SCL&B(+I,(.M_&&8=23=U^Z7=
MR-IY8DC&> U21+#_"C#XN]S^76[_#YC;?_!-*IWV MG2AB54[^+\&,99Z:-P
MQH,ZFZ!02NG#.VG0($@\4O'\=6\\#M6(P1$1II[H$Y!IE[0:$C)IKZJH_HG9
M##TCKEA2/IMTJZ&[.+0?LS,-\!*K!U7OV*@/S1MX#+68"KOQC-,U",M/2>TG
M2JZR[G:D>GP^2GOTN.?KTQZS(^!!^9.ROR[+9'NH5*D^+V/5SMSU# H;;HIN
M88"*J>E09^LQ&K[=G<G"+-A64R,/3(WQPCOU9$:,C=T64$@$D0P*A'5S(3M@
M. GW/F8Z^F=;-[%QDZ(-Y*32;4BU(Y9:PP7B!',;7<E>5M,=W^#GNC2^%08!
MPV@CM#\GQ )QN[1_ K:U'6)*UJ&C^Q&.F=SF5WALW7KB6D@;M&A.="O"G,-%
M_9)"9/25BZ-P@,4=ZUQ#*4IWX_EQ3. F^$EX;= K5L_6D;I=2,^W\@/E.MG#
M!9>^RX,TAJ%_6_%:FVLT9-#1)/-$'%\:*IQ:E/BPK,;6T_QL;T$7Y\N.'/#!
MTQ/0D1)MTP]P]L\U,/&T75^ R;ZL:K_E1Z$G_OSI6>B #Q]'3WG&RI'Y/L(G
MZEU%"R&3&=)1D@M%<<V<&2LIBT,U1?[ZC^J#M0RX<OA\AG\LP/+TG[+*-RA1
M[(.:'N9>AH'C*WN4*]Q)L N6Q;0$A36E7TPJ,)8OJBG=_O##9?&/HITAJR$V
MXN"FZYR68-GLCBW-E5R5&*+AEB@XQU*(GP>74=3B*=U6:H15Z@;=K\) C-]Z
M0Q0VB+\XIU$^1 ]5?BK'$(0( 3[!N7)*T=)HI^)B61HO<U?49:>Z*2@>'VL#
M^AZWY)$;:%8Y.P85A9W']@98D\'S]QX\]3"5A))JA[8TAA;&!+&U&ATCCDD(
M_#08$>$P:OH:!2]VU\CZ,8;M3FX6\-IN1HS5 P<YW^L6"8]J3ZOE2P/QF59G
M>1XM4 :XT@LEV^K6(+=U)W;4S%L7!,X%1QZLH>MB$9 7\()K0TY$HXRME72C
M=3@"ZI".M<)78+*A:34KIQ6_O%TOI$QVSB:RKO3VM71,8Q)#[)J:)6M1E5>F
M0CSD#3/7EMXNI%8#_)/KB$#[#,O@M4&$409/,3#9;(6&R2HXB\L6/FH6ZNE9
M: "(:C-?-[8E3I@N>>WO+H]@NAK#S 'KA8827TP&AH&3W=Z<CQ%[%.D.E#B2
MZ$@"6AH&XM=76$+32C67^Z-LJ/R5^\&K@K VRG7)FF;, $DOXEH-<KN<A#GS
M2R-%WN[!R%,TK<"-".%KB!%K32D;+F7<B,M)D1GYB5'O:7/":'O!QF!JDFKH
M@Z)?>UW; F XE>N:.*+@G[7N*1TVF)+[17BE!_Z]X?8(+O&L,&8%'K$+]JZ"
M+UO&D!F6+/8<+5?V$%#DQ3I7BI#&]JLH%O1.8<LF+Z4F$FZIL6]:4W&_("*2
M[$A\$4;Z7,$R'#\6OBI"'HP;(MQTH=*/HC-#)@;N%FITVZ]#CAR:3A?-@8):
M&%5N$MU,[?11,.;8G[G-#8?6 :LT#-YX@\-H@.1!HX:3>UCNI&=E#'O8SMYH
M'O$6A)P9-=U\70L%MX8@2#%CP:%\*E P28[M7$HK7*M:0ETI"+IUUSE6!K+>
MGKCS&9N28FAQO.YFELWM4WGE)Y$<=TLX']<L2^?6I0L7IM.5Z<*E\1?,KGN%
M;@_%+=+-L<>%,< .#/RIS?AE\FDF&&P^UW&98=]\_W>DH0;H-ND^+.7VCDVC
MHC*"-$8C'W,M(M]:(ECH8^=DQW!@^TG3+4O0\ PTBJ >:=/ 6UHFD)!FW<"_
M[P@3E!_*=LI0;&H?S?:LV_$4 C",S)((]*"N*+S+;3Q;<91I$[:%RMG5=DP&
M[!Z:4SO%%:&RC-_6: TR/PC!DZ*-B!]%]GHX+#JA/*XM8SK 6_3A?:E"[TMR
M^=><1#+(ED\4&-P+0[#5EZ=VX2YX((X0^TY7FA'P)40($RW8>:8S0+"39HF2
M-,U62!I$8):B-P3(HJ!@1C,I@BC;*W1,);:7_D.LW_A3=;'DF.%JPX.R,4>D
M'JR#CW=(/->3O$XO:PPH$5P/#>2RQX%CI$2>B8MV[[*Y-CJ@LOOG8"=; 36C
M6^XC.\,PE6DH/HA-A>$G&*-QL+:G!4P\9723/8#AL@$5#VOVVYH:S@8[3A=2
M<F8W8Q';=7M\BD-A6,@DN^E9%L-LG;UMTY.S"*^MI^CQOKQ3O=*CP;BJ>HZN
M+T^$2YG,Z&Q<)3FZQ^+5V$?>GN=KJE&?JK?LGKB/W'-N(H'E#E.X,)CZ8JQW
M3VJ!HMP:QR=W;H OHC*54> L$L>?LF,54]>BCSDH"3M:^$NO% J8H#_SS@GC
M\EY] :NK$4@R[$#OE7M)QC]CY /"Y.1]HU(?:A\F/>.H*]\>HL+Q*C#Z/E3L
M'H/ :9VR1ZWJSSL/#)?CQH>3#N,]3J;_[>3MB=YI&(!P;&3V#[:62:61:J4[
M;:$X=^48%(P#':AD1AY?$G-F/_R*7O($XTFG7\,!.GWXU;&O#L,H#*,,-"_O
M%Y#IW09CVV8\TF-I=U7Q48$/W1:S: $Y5@TKRRIHC_RDH+-G<;( $8*%37@'
MY;R\8FG][-9A9(P);":K%.=&&O2')#6VY@;RN(>H1"RXE2C=/?=X28H)> =Y
MJ'-V*'S;/=YP0_K#R(=0CV3J,!8W;@ZRFV7U#EIX!RV\@Q9^E#?(1?1/-%WR
MEKUH@1+NY<*MVM)E6\0)9]O(^>%11GVKGL>HET##JCD\KZ)"!TFN^7: WM$8
MK:=)0+TP*-A6'D/8-R";2AD_H[BC RAA_9:&>K2GN*1?7= F]VR'\(@Y-]N2
M4$R'H2Q*V&&8IIX5[8SO6?@D#EW;5I-W-84/5$R_9 (S+A3+<Q:>HX'9SUGQ
M&//):9^QH(@W7S6,TBM^? N/2D:M6W9"]ASRDQ<3"USZ<G2CPJ1^P)4MMUC/
M=2@J7'M'G/+;A)P2H:7H_?N%EAX/' 0MJ=V6$,?KLFEQ:9J:*\FHIEIC@'$2
MP.&#ML;[=X3]]*F58'A9AMORJ@)%1$DS'E;BFYP)4'_ -#X)D_1. 9 G;Y Q
M4?I^^W8?8K#.MP&R(><7Q?6.WGVQF?N]%M>2B=G32>QI.LY03:4:%@LI0212
MFS4UH?;P*\;N#5J).603JQW)$#F.-@3.U6OTC=>H359@*!072O^,X2?Z]YJ9
MQCR75RXE=/3718%@B8 RFMOQYM*"B!)*]#,RFA;$^[_$+ 2:RYJ(0LKOIO-
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M5[[H'I,@[(US48X"8A (H8XT%'4LV=6(*O@/T4YYE&15,(4=/@YVOB6&OB6
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M_ ]9-A@]A/D69 +2VCIARP-=4G@!Z:(/"8EC*Y?]##[L<0')-@:>\H.L]9:
MFV2D=PT8[66B9U0 @J!6[9U<?EC9PZQ8]<QU/SC$+>3$ZO,GKX44X>660+UI
M#:^_\H#BUN.,!R9,@MN^8B(#!U:-,:H:&5W7B^)ZOEX$@-\<M H6F% *#*&P
M86#??0=A+W4$8O)X8R53EGY[.!R'%AX:B^F1,"Z1@V*2@*!E8#Z@G"%#!N[L
M0"%*@Y)Q=:CT!4L7K#:MJU?E-6:QCY9,6_@%\YB@Q9;[L;?EA!X,8X9'X;T]
M7ZPIOBVSR+/WU?3]I)B^3ZRG?$:ZH%]Q>P*EQ*&*6.7TXM@4[Q6OGU85Z$^Y
MC7K: @*?V9X(UOLU14F=I?#JV9.GZ&9)?T[4"#_A-!E0\UQ6ZC7W>'\ENT'A
MC/.@F_U/6DAB?0Q+HA"]*.1X)Q]0WO4$?+8U'+/7&"HFQ*"[5K[Y)J1YV&[+
M&/ME:V-0/:]^.#N:DB^9JEKH._%ARZ):.'0PPH4ZWA\LU6+WEW)B0EG$J%WJ
M$-=..7 #$V9&NOFZQ7$7M?*K\_6>>Y%"$TU"VIB)PI=:.CJ7T_(0?1H4^%4;
M0[Z[<HT<^?2;IUX0F>K8<\4$X<<R6005H('D1YPIP3&K?%!G&_$9"0+LQ[$N
MIC[$:QI.4*J*)$2_+R,?ED0,'Z"E$9+7:0LG^W/W_B'>C+&<IDC!=< ;(!]5
MCSM_%?,='.D4196;I*#?$LY?%%W73$V.LV'*8%QG.,7E9;&8#R@7"6OVZZ#/
MMY8^NI<)^IQ+-AUW,7LWIIWM2)MO7!AWYF+%H5Z-06F-KYVKM]?D;D2@1[LU
M50<O9(N**.YRXU\SQ:4S4RQ0$W>ZJEE&]8OZNYF=+0D33IF7$L7GHN&DM= 1
M^2F MH:3"M+(H6!0C!(,H.@GGB/DV;LH6@K)$C8?=JYNZGMT05FP?>=62T-B
ML-AWF)L[S,T=YN;C;'+&W+PMZJ V\(8(FGJ_]KQ-NQM^O:>ACR2Q3&2]V*AR
M=ZP8.AEG7[GIJ0V3%;-E52.8UD0N7[&]:^RZ,R:;%4)4'0,IIW>H2-=@!CY%
MWDOVUJTY]_SLR="&$[;>EV*!20!B R]8U]-J81_PMY=O$P]XMD:[!*P>>!*:
M6G^!E?FE^+4$67(+[D:F5]%ST_*>$Y_77!KM)VP&]U?0Q3.P^,U8_O++NW H
MT>7O%QR[:'4>DLP7]Z29H1UE^X7HI9XGS01S8<>FJ1^4,#S")066V=2/(60B
MJQFWM2>, 5T@P5=?%$S)0!<SMC.IQ66@_'#++6K*%K8/P?4:#"=LE(Q<$D8]
MG,:2[$PGA3LMZ"?8AK* _ZXG\+_G<(GFV4MBWOTK[&7!=_K;#2B"(?;68&Q3
MKE"FM&,.U"7;KV$R1HM3TQCG?$8]KY?4=N8*C'JV8RC_JX^30V@KWWX% Z'/
MT!+"JG0IK?.&';M<!%$6*AM-MJW6+<H3U=$R-88$5\6=-NWFY2&C2L$M_@F>
M!W$!B%D6S"SDE8U V>/=H'%M47_!6!:;L(S6]ZQ"RJ"1#R$RKG"9P "UXIJ4
M6:R.;=D@>R4/B+Z/ @B_N2[VE4/E(92@",NU63>_9@<8K&)$WB_H%V8O"O*3
M<<E##@S'MSO,E;2E-^.EY;DZ%$&'1=O=;$ .84HZ##4,EC??>U^6*XUJ>R97
MVT@CY'ELO#O^$P))WV(C^JG4&(5P"2&T/#^W5X.^ZVT/!^P"?DMU@6?@H\,(
M\5NO*6E-OS0$[.\:)+5]8^K3*3#":55XW*L)\[5D[T"9@C?=+4TZYC0[^MO;
ML^SUV;LWYZ_>":DWK3(=\RD?4[W?@M#*&[<D/CQR/PR/D"+Q*TPA /!"W%9K
M;TO\=NB+<*=?N]VRN9US$P>/WQF$40]1P]0&DRF]->T7X:\7:[B6$(+<*;50
M'MHUI%&)S,;=R,$MC%XWK.'6Z,_H ?#6@%"PV69K%*KT;=XG= E-2O065=EP
MD\W$>/*P]RQ:#PXJ+,W=&ND!=55%^?,45C Y ^YW,"BDW=K,6BMI#U$;,L+U
MR6:"Y9MLM3HMV):>9@_A8&K53EIF5?0-/Y<:1N-H5%SOFP#I].7TL@;_\6*3
M*5?A&C-]W*B$P/[]==.^)W*0=G9-^>:NF??\+TKU'(5TM_0[L?X<,,+'GHBO
M7! 2.1HM,R6ZXF2Y;W9%#S($&2SEHU&H<;L3^ZF!?EQI9L%,FBI>L8B:.R.O
M._<>M9'V,&NW'O#S=V!)TF+2)#63EFPPRK<(627^7L/;9E9). XM67.=<1%J
M4,5.6[#F&@JL>9];5T'+H<G9;"7:E#&P:DI&N!:=._IQZ40MM:ZNOV,WZ.#0
M@>*G*6(^R*Y<T)Z)AE01 Y7R7D9M$,7@G!.Y6)!7V$E9Q.ZM6Y]]3HH,/K%+
MDDK::;1RLSEE"M]J;H1,&@OI<NCN0246_74]NQ +@Z)#VOUY<+O)4CEM;_1W
MK/M] !3]*7<#Y'ZC@YBG8N6Q09F'W(:;?O3A6)"?+/TH6-0XFFQFRAJX]L^P
MW'WI<DC2^!E>].>FM2S]2,X@['6XEBB0("W2@\9K+7FCYHSY,F1$W\3J$((>
M'&V.Q2&KK@HQ:9QD*+?W</M9E/^AW]7A;_L&#69=:]X"(=6X'-P+*,] WGSK
M',DWV@[LR:Z/BO\ABD-^.<9F%D1OC0*Z#]O77GTAJ[VDG1[%>4')(''74],M
M"%9EU4GCJE[[6236R]K/R-EH$3X8WERO<K]1#)SJL-"<N)Y0MC=$>M[E-D)/
M[KK7[V&7*1D/.=2) ?UQ#8]O([OCX==L=TR.$7;^Q'3D1NCY27:&6L7_-I.L
MAX:=TC%#-):ORO9C$;\QS0,C@/2,&YQ94#O@*@64GW-KPB1"%8^,M^CT+TO&
M.S/'IF+3)G_@!GDC O/VV9-WYZ]>9E^?<%1;0#=/>>?'%O*Q@26257MHRX8]
M$>"<O15P7*J @<_=*^%:4YH*0A<$<MQ902:%[$L$E4=N9H-,_@A%Y)+R1==U
M+!_E1O9-B%Q5ARL*X\,Y3Y6=H#V]HE9?T[):]6,U)@PSL 4C$F"C&P]K0":2
M95W75*;!QJ;'&2;K03PBNI>).A\*>[<RW8>T[Q;&#Q^ U7XB9;(C8C#O1,7A
ML"38Q5NI_Y<V\C/@N&CI!"^)5SPW04M?M.5\3EW$J"%XU[MB/OP.BRV:8C.+
MS42(K>):"N[E%YBC@_A)(Z5=A-U)+?1ZY?HE$U>RGQUOFE_574L9O8.7XF3_
M$CGQ.[#94X%.(@5-@D:92?D3W#.^'FT%Q$;1L5A0"#@UY]Q[!LF'<5\;>'O@
MF(65:RG7TL(P7+1>.M*Z*G+:CN1.*,R.)40>1V6QA:.L'3F#4I/^Q0M;D6B9
M5W6N_<S7>63*QO,\G'K"P[MCV98U!1!;;]J_\5WB=VB@E(VT#O5SYU\S=Q69
M8[6)I!2HG9$6^G285P5!?5#/CEV=\%.XZHX:88LKBQ9#9-FLH&)%*N&<P:*@
MTR.'BM[,YZ>]=UUL]/QA$[#%@JDN)""'=4V2!Z:G\W@Q<D'HTB,,C^2^(A)M
MN["0)$#'DTI.'RV). 7)9GBSD/T<!0Y?B;!%(] $745\E.D5XWU;VQ\5)O/L
M Q%^93\1=S]]I=MB7I$V1O<W$YX RBW5 A_$'^TN5$L,N7$KCG M[:?<DDK#
M<%K*[9+@LA&\AG)C8M3#I'?)B8E<*7=5H#**BWR43$ -K6UV$3&]1@41+TN$
MN_( [$:[JQ%;'2S<-:]Q!:?C418=_?*(BBMZ*W_I8X)7-XY/RTU [4E7]#F!
ME),ZW1FGEOP 0TK*H>Q#?DH#Z#D990;%AHYYY!5:':\WS /M&23WS+&YN;57
MQ&S-7M'(8T><39^H2KWWV^SWYVZY@^3=0?+^=2%Y8V;"E,P$%['8Y8[[O"K=
M,9'J)0R/Q\0XGR9R>9WV9L5L]2UIBTC)5[7+L:I;-'AO#$F2II<@!]SY$,UR
MC<,S_)M:RY08-V^;&I'HBXW_!+*[WRL)H$()@;)+6*5&5W-3:KI,8([,OJ5W
MY)B"EN(AP5"7-JI NOK(E^6/VA<4?F9D<[ "+5*8U$+R[%9-7X5WE ='1FMY
MC'<3WL9/RU73,=[L'3*LFPI>[AN'HY</D8+_N^\Q"H]X@KE.L!IJB2N3Z$C5
MBW";<F7&7*]W_V0<EG"7">:JWS8@,C8H#;9<]QSW%P># BXB=9(!H9O#P0"E
MG!=C*YUWA^;P91:'&?,9J&!H,X +Q3P(QPL\YJ)I9CH3I;E<TIE)GY11=UF>
M(0>'P1G!$2'RCV5)MC!7E%%"VPD.;[.G(K+F4LZ18][^/+7_483!!!2J86.-
MQ+$Z"ATO;)$T+]8+9O@BWIO Q=39)H]5TKP[LIY\1Y%MRG=2U&VW8R^G2LJ!
M3&]VE<+C")GG5X"23\6,(X:\Z.0>@3&-_@9!*EV76[P9I6.521AZHQV^I];,
MZ7V,B+)<YF@^DQQ0'2%JE*1Y5+1+\MALSS]L[9HSHQ;C8G)+[(L$>;FH0UPK
M33]*)RMRGEQX@_)+S93*I:CO(U<;&H_%?)@;Q1&S&W%G\X<19V Z'V-Q?M61
MA['N!9&1H"\1144BDVK,148F5EJ-V(U'"@N8K4D&\<G'DA8>&L3YB$7L]8.F
MVRU]HD(1*"*%S5P*)-+K@[$?7L!A)I8$ J2Y$!&,1\M>RT;$^=ST$QWWCK U
M&YS7ZR8[>G#LZQG!T>RV7E]T>+$9/8A^N29GV-WQ)A-OLGF=BT=;OU"O E2V
MO*UF7AJJTUM /U072T^NO>7&#H(K]$U9$E:^NP:G?BB7PCI@-'ZR_.!Y\]GI
MFKXO+L9IUW  I.\E^X_R\G^;]CTWX?,1@KJ!!QX]HWQS35;PL09O[-YLW9J#
M.Q*:'OSFA!E6P$PKZC[&[@Z9)J;NDV.TJBAC'(GIOC^T597L89H7&Q'"]8PS
MJY2YG_=B2G'8;Y HIXMNW6K3$4E)51K+*BQ30PP@3-HLU: ]L8]>C9S!4:9!
M<]WB55FU<"%S;P(%!3OE(2AL-83Q'NM(P]CP"1%WG7[S8/R-$0KX.!_ U[3@
M0^.: [Q""Q^D.A!)B1*9SJ44SF-S!51UN/*Z4ZHNTCN:V\R-FB2=:87$Z]J6
MR&8OW1TDL\EMKMT9>N(, (5:\2?AYB^%Q,7T7S C]<1ISNKP0A&]C5N4.H,#
MO\.,; 'IGH[#I:A(^QM[1S^@22R_6$V;&,_(88#/AH3R]#@Q8$,2N 2\CW9Z
MA0S+4ER ,TPM9^XW?6?.W)B-,NL\G& 7SK"[T12=E;[G$)I550N) !T;CX^B
MA;J2_@4CW,2NK8 !PJ7# ^FC<F0X+D%LFVOL.F/(+MD-9H=F\'CGT%!YE#4B
M?.Z!NSQ?A;4#(IW&#0LPLR[PRG5WPFVT;3G1TV'<Z6+CNW-O16F0Y3+D,@QU
MLV#]_0H)&X-9G::FK.RRG&UA>36&5PJP;]J7^J5D\D1O!B)0JV0 QGN]*SA:
M;O*N_E;!UM>2N!T[N?!YTAB/$U!#5U1')^X3G?^;*](8TISVT9%SV>$2!YU!
M1K\GZ!6L<%QM&*@ DNFT*:A?X>$=<?1P*ZE"TAQGN;WQK."M(Y%*VF3>3ZU>
M3%$'1ZVE&H(,*6 &\;V?^+3R"W##_BCG-5T<"J>VKKK+451A6&\H&Z7R(.(A
M:Z!2RPM.=XU\GGA+".G(-M>H5'NIW._,#,H1_,GQGM=5563/GOY\]D:QPU>)
M\\R1%PH&[CC-'W-F>?I;+!]CGL;04I/BASN_N&B+%66>R6Q\]. 18@J2+7E\
MU(7(QP@05]NO'7T[\LV#!6:\=*%YLSEO^V:5O6JY$T,5>84D1&23E*F#9(PP
M3A=7O6:A.Y<(0-@5XB)MGTLY:KG#&'0H%/QIT\_1_7IHI,KI['#TE"Q4)*$&
M0YUQ;9N;CY\_U7@D^OQ T$Y$;<-5R-'C#?53:.[B4[9W6<KE??A=?FIGC#G,
M\[MZA*T6WIRY([CB3Q P6G\==G%UK\-HK9^,7<CR0PD;2>8_^@SLC8#:"(9C
M1UYAP6S42-&A.<BM=<61'A>G62&I>G=+P2/P8:1D_OVH'%,%IHOG]ET.TPGB
MAT6UY'/"FKG"3K:UW"#.1H:PK9N7@;CX;R4.&LK4+NP?91-(+J.#$Y^'/"%?
M^(FD?.V2*JT-_&CYH>S%W/_9G-_*]6)VWC!A5?R;6GD_PK@ZNG98L[!H5_,^
MN,5Y@1C$A:TK&^D3OVQ0&@[O#AAFW4?.">Z1UU8G>"LH2WC8,("#U,Y"\$F*
M%9$%(G)KU":P)YS,F&$^?:<5)\516LURI%LNB:,PY'F,5IW)[(Y%?B*-;L)A
M:##O80^Q!%;UL2LF-'$&K@RX5: A=Z=P^_7"O1>1@*'=9I3=)@ Y>A5M"T#N
M$VD,EW;GH/D.X5&[J>YIB^ON4,B&:?"H@PKB\M16=0Z9X#Q=>E)3)[^AZ H>
MFIF_N5-S,U5?)IV/P9 /Q^30]< 5Q?^:%VI.Y@YC=H<QN\.8?71F^(GC=]S1
MZ_8DPVONG,P&PAOY#()5AKN;04CFU/9I&FC$A*U8.*J.G6551SN8M3XV^4+6
MW)4/8@IJOO6%:_('ZO81PV$<A &IZVWE+UV"VRZ[OKDHR?OR"4BS\+58B3[B
MZO_H0I?">$Y30*JG-1.ENUJ$PA,#(+<!.1^P<%3U0HR\\0?\#/P ))Y&UK4^
MO--KA88!M]6B+#2%QL8IQK]D5\.<&JTBW8$F*,7K%T#0"U<9PU$WKDERP6(_
M4I%@YM>5:^93+7[#A H!S-*S,:5=HX1AYZ(&6W)ZN"?L<@\<J72UX= T2(8&
MW;OWR3)M#Z=[#& @Z=)R2!T<&V0P.3@K1UL,\6@K[/+'>5BNP@]CQ29.K*N
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M'/%;7;\RF&J)BE^MES")@.D?:GV=F+SGJJQ!^,Q2)#X;9-M3S)\TEF IT'7
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M<4=_J:NWN!5KN'R7] 6;CFH?;PF0X-INW:K4B7)'[KWRXR[G&Y2X;DMP,N^
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MX:<S8J=0#S-!,%0@%Y9.;\\H AU;7'E27M2,T!]#)T_OKF2&('T/[PH]7H*
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M_-[]0/]JH4T[H,>2;\$1;</L<E< R/UM(R7HBM"\5>\<=?&Y0S? ]4=:R-\
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M)4TP9[W_T>[M[^6H?P:R_R-@#F>HYESJRMC./_]((WEZ8 _86"^$LHY2SC6
MGPLS.I#WO@G_ZZ*W9;+Q^'*GS*UZY M*F?8_)WQMF?0W^Z^1'L9GUS?==7;:
M2A[O;JY:8[-)U^C%]F JT'2$?+DSC[2R"C[0/W? K_X_3'X'4$L#!!0    (
M ,""<E7=PI2T? ,  # .   1    9VYP>"TR,#(R,3$Q."YX<V3-5U%OVS80
M?A^P_\#IG:;E-%MLQ"F*92L,I%W1I$#?"IHZV\0D4B6IQOGW.U*B(B5R([M
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MY=<M5E&UHF9# C(!,M\?I"3"PJ,I2W=3GD+8BMFS'P%6_0?_7:E+;W.YF3C
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M.3 S-"YH=&U02P$"% ,4    " # @G)5W<*4M'P#   P#@  $0
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LLP  9VYP>#(P,C(Q,3$X7SAK+FAT;5!+!08     !P ' +\!  "<QP     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
